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The rising cost of quality healthcare is becoming an increasing concern.   A significant 
part of healthcare cost is the pharmaceutical supply component.  Improving healthcare supply 
chains is critical not only because of the financial magnitude but also because of the fact that it 
impacts so many people.  Efforts such as this project are essential in understanding the current 
operations of healthcare pharmacy systems and in offering decision support tools to managers 
struggling to make the best use of organizational resources.    
The purpose of this study is to address the objectives of a local case hospital that are 
typical general problems in pharmacy supply chain management.  We analyze the pharmacy 
supply network structure and the different, often conflicting goals in the decisions of the various 
stakeholders.  We develop quantitative models useful in optimizing supply chain management 
and inventory management practices.  We provide decision support tools that improve 
operational, tactical, and strategic decision making in the pharmacy supply chain and inventory 
management of pharmaceuticals.    
On one hand, there is considerable progress to support pharmacy product distribution by 
advanced computerized technology that manages the dispensation of medications, and automates 
the ordering.   On the other hand, the available information is not utilized to help the managers in 
making the appropriate decisions and control the supply chain management. 
 Quantitative methods are presented that based on the available data provide simplified, 
practical solutions to pharmacy objectives and serve as decision support tools.   For the 
operational inventory decision we provide the min and max par levels (reorder point and order 
up to level) that control the automated ordering system for pharmaceuticals.  These parameters 
are based on two near-optimal allocation policies of cycle stock and safety stock under storage 
space constraint.  For the tactical decision we demonstrate the influence of varying inventory 
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holding cost rates on setting the optimal reorder point and order quantity for items.   We present 
a strategic decision support tool to analyze the tradeoffs among the refill workload, the 
emergency workload, and the variety of drugs offered.  We reveal the relationship of these 
tradeoffs to the three key performance indicators at a local care unit: the expected number of 
daily refills, the service level, and the storage space utilization.
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CHAPTER 1:  INTRODUCTION  
A recent visit to a local emergency room (ER) motivated the author of this work to 
literally investigate the crucial element of supply chain management (SCM) within the healthcare 
system.  After experiencing eight hours of delays in the ER waiting room and witnessing 
incredible lags in the medication dispensing process and even further impediments to the 
delivery of treatment modalities, the researcher became outraged with the thought of a high-
performing healthcare system’s lack of better supply chain management and service delivery.  As 
a healthcare consumer, this scenario is likely to happen to all of us.   
One might contemplate how an industry based on customer service falls short in the arena 
of inventory, patient and materials management?  According to business researcher Vicki Smith-
Daniels (2006) in a field where precision is literally a matter of life and death, it seems strange, 
that a crucial supportive function like inventory control and purchasing is often a hit-or-miss 
process.  Healthcare, unlike other industries has not given supply chain management the detailed 
attention that it so rightly deserves and needs to ensure patient safety and reduce overall 
healthcare costs. 
Inventory management in the healthcare industry presents several interesting challenges 
both from a managerial and operational perspective.  The stakeholder relationships, product 
considerations, and managerial and regulatory policies typically seen in healthcare are unique 
and worth investigation.  Before delving into specific inventory control issues or demand 
characteristics that make healthcare supply chain management (SCM) particularly difficult, it is 
important to recognize the magnitude of this industry.    
1.1  Magnitude of Healthcare Industry and Impact of Pharmaceutical Costs 
According to statistics published by the Centers for Medicare and Medicaid Services, 
healthcare spending topped $2 trillion or 16% of its Gross Domestic Product (GDP) in the 
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United States in 2005 (Centers for Medicare and Medicaid Services 2007).  In addition, this 
percentage is projected to increase to 18.7% in ten years (Heffler et al. 2005). Catlin et al. (2007) 
state that healthcare expenditures increased at an annual rate of 6.9%.  In addition, there has been 
a shift from public to private healthcare financing in the United States, as well as other countries 
around the world.  Most of these efforts are an attempt to continuously find new ways of both 
controlling healthcare expenditures and paying for prescribed treatments and pharmaceuticals. 
Especially given the current economic crisis, a growing amount of attention is being 
given to the rising costs of healthcare and specifically pharmaceuticals.  Healthcare providers, 
insurance companies, government agencies, and consumers alike are forced to address this issue 
and to explore alternative methods of cost reduction or cost containment (Marmor and Okma 
1998; Jönsson and Musgrove 1997; Culyer 1990).  To gain a better understanding of the 
significance of this issue, it is prudent to first identify the magnitude of healthcare expenditures.   
According to The Plunkett Research Group (2008), “The health care market in the U.S. in 2007 
was made up of hospital care (about $697.5 billion), physician and clinical services ($474.2 
billion), prescription drugs ($229.5 billion), nursing home and home health ($190.0 billion), and 
other items totaling $668.8 billion.”  
As shown above, the financial aspect of the healthcare and pharmaceutical industries is 
quite staggering.  Much of the research in this field has focused on the relevant costs of 
healthcare (Castles 2004; Comas-Herrera 1999; OECD 1994; OECD 1995; OECD 1996); 
however, Rothgang et al. (2005) examined data reported by the Organization for Economic Co-
operation and Development (OECD) from 1970 to 2002 to investigate trends in the level of 
governmental involvement with healthcare systems.  Although some shifting has occurred over 
the years, convergence towards a mixed system of both public and private healthcare seems 
apparent.   
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A significant area of healthcare costs is the pharmaceutical area, which represents 
approximately ten percent of annual healthcare expenditures in the United States and about $550 
billion globally in 2007 (Plunkett Research 2008).  Despite the size and importance of this 
industry around the world, especially in developed countries, the area of healthcare supply chain 
management (SCM) and inventory management has been given relatively little attention.  
Several researchers have estimated that inventory investments in healthcare range between 10% 
and 18% of total revenues (Holmgren and Wentz 1982; Jarrett 1998).  Any measures taken to 
control expenditures in this area can have substantial impacts on the overall efficiency of the 
organization and its supply network and, as a result, the profitability of healthcare providers.    
In 2003, Guillén and Cabiedes examined the pharmaceutical policies of European Union 
(E.U.) countries from the mid-1980s through the 1990s.  As explained in their research, the costs 
of pharmaceuticals continue to increase while countries struggle to find financing to support 
these drugs.  They noted that much of the healthcare services are shaped by the pharmaceutical 
policies, and they also identify three reasons justifying a focus on pharmaceuticals when 
examining healthcare supply chains:  the reliance of modern medicine on drugs to both prevent 
and cure sickness; the significance of pharmaceutical expenditures around the world; and the 
pharmaceutical industry characteristics (i.e. use of technology, innovation, etc.).  Almarsdóttir 
and Traulsen (2005) also identify a number of reasons why pharmaceuticals deserve 
extraordinary consideration in controlling inventory.  These specific characteristics make the 
pharmaceutical industry a very powerful force in its own right.  
 As with any industry the range of products can vary tremendously depending on the 
market, customer demand, the scope of services, and other managerial decisions.  For the 
purposes of this project and the specific research case presented, the focus is mainly on the 
supply chain of pharmaceuticals within the hospital.   
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1.2  Special Conditions and Terminology of Healthcare SCM 
The stakeholders and their interrelationships, the product characteristics, and the policies 
employed all have some impact on the healthcare supply chain management and inventory 
control.  An explanation of some specific conditions and terminology used in healthcare are 
discussed in more detail below. 
• Stakeholders 
 Here is a brief summary of some unique factors influencing how healthcare stakeholders 
interact, how they are controlled, and how they manage operations.  A detailed analysis is 
provided in the next section. 
 Doctors are the primary caregivers in the healthcare system; however, it is important to 
recognize that physicians, in many cases, are contracted service providers.  They are not actual 
employees of hospitals in which they work.   Although this enables hospitals to expand their 
service capacities and offer better customer service, they must also relinquish some measure of 
control to these doctors. Autonomy, as it relates specifically to customer care, is valued above all 
else by doctors.  Patients trust that physicians are prescribing treatments and medicines that will 
address their individual medical needs.  Attempts to restrict the choices or influence the 
conditions of medical treatment meet with a great deal of resistance.   
 Another consideration is that, unlike many industries of this size, hospital 
administrators and pharmacy managers have to manage very complicated distribution networks 
and inventory control problems without the proper training or educational backgrounds to do so 
efficiently.  This in no way implies that these individuals lack the intelligence to perform these 
tasks.  Most hospital administrators and pharmacy directors are themselves doctors, which means 
they are highly skilled and educated in medicine; however, they are not engineers or supply 
chain professionals that are commonly employed to manage similar systems in other industries.  
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 The hospitals order the majority of the supply from a selected group purchasing 
organization (GPO) that purchases directly from the production companies.  
• Products 
The product formulary is the term used to identify the variety of drugs offered by the 
hospital pharmacy and is a source of both conflict and cost for the hospital.  This formulary is 
comprised of specific medicines each designed to address a particular medical need, but 
physicians’ opinions may vary on the most effective drugs at satisfying patient requirements.  
Providing prescription options for the doctors is important, both to the doctors and hospital; 
however, this increases the number of drugs that must be carried by the hospital pharmacy for 
patient treatment if it desires to maintain such a high level of customer service.  In addition, the 
product formulary changes quite frequently as physicians’ prescribing behavior reacts to 
advancements in medical research and technology. 
It is also important to recognize that pharmaceuticals have a number of other 
requirements.  They must be handled by trained personnel and experts in this field.  
Extraordinary resources are committed to developing these items, to manufacturing them, and to 
controlling their distribution and usage.  All of these aspects are highly regulated by 
governments and other regulatory agencies, and they may require additional documentation.  
Finally, unlike other areas, customers have a limited role in the product selection process.  As 
patients become more aware of alternative treatments, they may influence doctors as they 
prescribe medications; however, more times than not these choices are made for them. 
Many of these items are also perishable and must be destroyed if not used.  Perishable 
items have a limited shelf life and in many cases have special transportation and storage 
requirements.  Part of the concern with pharmaceuticals is that outdated or expired items may be 
overlooked and dispensed to patients, which could have potentially disastrous effects both in 
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patient care and public relations.  The perishable item inventory control problem is a difficult one 
and has been studied many times using a periodic review approach (see Fries 1975, Nahmias 
1975, Nahmias 1982) with less attention being given to continuous review systems; however, 
there have been a number of works in this area in recent years (see Weiss 1980; Schmidt and 
Nahmias 1985; Chiu 1995; Liu and Lian 1999; Lian and Liu 2001).  Although these studies 
provide valuable insight into the management of such products, none of these models have been 
tested in pharmaceutical inventory control.  Given the combination of high costs and 
perishability of prescription drugs, it seems that more study is warranted as pharmacy managers 
look for help in setting optimal order policies. 
• Policies 
Substantial efforts are made to regulate the healthcare industry.  Government 
involvement is high as it can provide both oversight of caregivers and funding for care recipients.  
Previously, healthcare systems have paid little attention to the management of inventories. 
However, with the implementation of Diagnostic-Related Groups (DRG) in 1983 by the United 
States government, these systems have turned their attention to cost containment as a means of 
increased profitability.  The original objective of diagnosis-related groupings (DRGs) was to 
develop a patient classification system that related types of patients treated to the resources they 
consumed.  Hospital cases are segmented into one of approximately 500 groups expected to have 
similar hospital resource use.  DRGs are used to determine how much Medicare pays the 
hospital, since patients within each category are similar clinically and are expected to use the 
same level of hospital resources.   
Interestingly, public and managerial policies targeted at cost-control have failed in many 
cases to produce the necessary changes in stakeholder behaviors to achieve such outcomes.  
Efforts to control pharmaceutical prices have provided little relief as drug manufacturers attempt 
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to recover the resources spent researching and developing these products.  These companies also 
target physicians and patients with advertising campaigns as they attempt to influence 
prescribing behavior.  Another reason policy has been somewhat ineffective at cost-restraint is 
the conflicting stakeholder goals that appear throughout the supply chain.  Doctors and hospital 
administration are often at odds as they try to balance the issues of prescribing autonomy and 
product variety.  While the doctors want a large variety of brand name drugs, the hospital 
management strives to minimize costs in the overall system by seeking generic drugs as 
substitutes for medicines preferred by physicians.  Hospital and GPO have different objectives.  
Hospitals focus on negotiating the best prices for a wider selection of drugs from different 
pharmaceutical companies while the GPOs are interested in larger orders from only a few 
pharmaceutical production companies.   
Inventory control variables are called “par levels” in healthcare inventory management. 
The min par level is equivalent to the reorder point: if the inventory level decreases to or below 
this level, an order is triggered. The max par level is equivalent to the order up level (or base 
stock). 
1.3  Traditional Operations in Hospital Pharmacy 
 Traditionally, hospital pharmacies operated in a centralized manner.  Medications were 
stored in a central pharmacy and then distributed by pharmacy technicians using dose carts to 
make deliveries to the various hospital floors and Care Units (CUs).  A setup such as this 
requires large amounts of inventory to be stored in a single location while also allowing for 
quick, easy access to items.  These technicians were charged with the task of moving the various 
medicines in the correct amounts or in individual cassettes for each patient.  These dose carts 
contained individual cassettes of medications for each patient, which the nurse or caregiver was 
then charged with administering to the patient.  If for some reason the patient’s drug order 
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changed, a special trip would be required to retrieve the necessary medications and then return to 
the CU.  Thus, changes in medication or dosage may have taken hours to satisfy resulting in time 
delays in care, increased labor requirements, and an overall increase in system costs associated 
with wasteful or excess operations.   
To avoid prolonged delays in administering medications, it was common practice for 
nurses to borrow a medication from another patient.  That resulted in additional problems in the 
distribution process and in potentially dangerous situations where patients may have received the 
improper medications.  Other difficulties associated with the specific pharmaceutical types 
existed.  Specifically, federal and state regulations require a variety of documentation associated 
with the dispensation of narcotic drugs.  From the time a narcotic is delivered to the hospital until 
it is administered to the patient, the drug must be tracked by the hospital and is surrounded by a 
number of tasks such as checking the ordered medication against the patient’s medical record, 
searching for narcotic keys to the cabinet, documenting for administrative records and 
reconciling narcotic records after each shift.  This example demonstrates some specific 
challenges in controlling and monitoring items in healthcare SCM. 
Pharmacists are highly paid professionals being asked to spend long amounts of time 
handling excessive documentation and a labor intensive drug dispensation and distribution 
process rather than practicing pharmaceutical care.  The opportunity to reduce repetitive and 
tiresome tasks was very appealing to administrators and pharmacists alike.  As such, the ability 
to automate these processes and take advantage of computer information systems was valued by 
stakeholders.   
1.4  Research Objectives 
 The hospital participating in this investigation employs an inventory management 
solution driven by information technology (IT).  The specific solution and operating procedures 
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are discussed in more detail in Chapter 3; however, it is prudent to provide a simple overview of 
this system at this point.  Specifically, this solution, Pyxis MedStation® allows for local storage 
depots to be distributed at the various CUs around the hospital.  These Pyxis® machines house 
the drugs needed for patient care in that CU, as well as, track every inventory transaction, prompt 
replenishment orders, generate necessary documentation, and facilitate the billing processes 
related to pharmaceutical treatments.  While these Pyxis MedStations® allow for the automation 
of a number of tasks associated with this supply network, it is important to recognize that 
pharmaceutical inventory management is still a very labor-intensive process due to the number 
of Pyxis® machines in the hospital (~85), the large volume of drugs housed in each depot (250-
500), and the workload required during the restocking process.  As such, the following research 
objectives are identified: 
1. Service Leveli  max, > αi  
 Here we are trying to maximize or set a lower limit for service levels for each 
item in the Pyxis® machine.  The service level is defined as an appropriate measure of 
customer service for each of the n items (i.e. 90%, 95%, or 99%).  Alpha (α) service 
levels are associated with items based on the number of shortage occasions that managers 
are willing to accept during a period of time.  If for some reason the hospital pharmacy is 
out of this item, it can place an emergency order with its supplier to replenish this item.  
However, the hospital would like to avoid these emergency orders if possible because 
they are very costly for the organization.  For this objective we are considering the 
service level, α, for each item separately.  To consider all items in the machine as a whole 
would result with lesser demanded items being unavailable more often to accommodate 
the higher demanded goods.  In addition, these levels reflect the average service level for 
the item rather than the worst-case scenario level as set by the hospital.  
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2. ∑ (Orders per Dayi) → min,≤ N(workload constraint)i  
 Here we are trying to minimize the number of orders per day (refill occasions) or 
at least keep this number less than the number of orders a worker can handle during a 
shift.  This is an attempt to account for the workload constraint.  Workers can perform a 
limited number of restocking activities during a given shift.  There is an incremental 
workload constraint, which only increases with the addition of trained pharmaceutical 
technicians.  As such, the goal here is to find inventory control values that will minimize 
the number of required refill occasions per day and not exceed the work capacity for a 
single worker.   
3. ∑ (vii Si)  ≤ M → min  (space constraint) 
 Here the goal is to allocate space for each item in the Pyxis® unit such that the 
unit contains the necessary drugs but does not exceed the available space.  The goal is to 
determine the appropriate amount of space necessary for each item within a Pyxis® unit 
by first assigning space to accommodate si (safety stock) and then determine the 
additional space required to house Di, which is the difference between the order-up-to-
level (Si) and the minimum stock level (si).  This is done to provide support for 
reorganizing dividers within the Pyxis® unit to allocate the available space appropriately 
amongst all of the required items. 
1.5  Organization of the Dissertation 
 The remainder of this document is divided into several chapters with each addressing 
specific topics related to this research.  Chapter 2 offers a review of relevant managerial and 
quantitative modeling literature, as well as, presents practical solutions employed to address 
challenges specific to hospital inventory control.  Chapter 3 presents the research environment 
and the modeling approaches used to satisfy the investigation objectives.  Chapter 4 provides the 
analysis and findings of this study.  In addition, the impacts of these results are examined for 
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managerial decision support purposes.  Chapter 5 brings the conclusion of this dissertation, as 




CHAPTER 2:  LITERATURE REVIEW 
 This research focuses specifically on supply chain management issues from the 
perspective of the hospital.  Other members of the supply network in this industry are 
important; however, the subject is simply too voluminous to cover adequately in this setting 
without restricting the scope somewhat.  As such, the authors have selected to focus on supply 
chain problems as they are viewed by hospitals, which is appropriate given their significance in 
the supply chain and the costs they incur.  In the following sections critical managerial areas are 
identified that distinguish the healthcare environment from other industries that have received 
attention in the past.  
 Pharmacy directors are turning their attention to controlling costs in the areas of supply 
chain management and pharmaceutical inventory control.  Supply and purchased services 
account for the second largest cost component for a hospital, and it is clearly recognized that 
SCM is one of the principal areas for improvement in organizational performance. Supply chain 
management in hospital systems all over the world shows a great variability both in performance 
and in focus. Such a variability combined with the growing cost of care and pharmaceuticals 
determines relevant differences in health service efficiency and unacceptable annual increases in 
healthcare costs. 
The remainder of this chapter will serve to address several key areas of healthcare SCM 
and pharmaceutical inventory management.  A review of the relevant managerial and 
quantitative modeling literature is provided.  Here attention will be given to both the overall 
study of healthcare SCM and the quantitative approaches to inventory optimization.  The practice 
of pharmacy operations will be described with specific attention given to the movement and 
distribution of prescribed medications within a hospital. Solutions focused on addressing SCM 
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challenges will be presented along with the Multiple Criteria Decision Making (MCDM) nature 
of decision making in this context. 
2.1  Managerial Research in Healthcare SCM 
 Traditionally researchers have taken two approaches to studying healthcare SCM:  
analyzing the managerial concerns and evaluating various quantitative models.   First, the 
managerial aspects of such supply chain systems are discussed.  The stakeholders in healthcare 
supply chain and value chain are examined along with the conflicting goals in the system.  
Thereafter the most common managerial approaches in healthcare SCM are summarized 
including outsourcing and vendor managed inventory (VMI). In existing research, the focal point 
has primarily been on description of the system rather than developing innovative models or 
performing quantitative analyses. However, these descriptive studies are important to document 
the actual healthcare supply practices. 
2.1.1  Stakeholders and Relationships 
The financial aspects of the healthcare industry are significant, but it is also an industry 
very important to all members of society as it involves a wide range of stakeholders.  Burns 
(2002) examined the healthcare industry for three years to investigate its value chain, to uncover 
significant industry trends, and to identify the major stakeholder groups involved with healthcare 
services.  Evidence showed that both vertical and horizontal integration were present in 
healthcare.  Vertical integration was illustrated by hospitals teaming with insurance agencies or 
ambulatory services to combine various portions of this delivery network. Noticeable horizontal 
integration manifested in the form of hospitals purchasing other hospitals or in the formation of 
groups purchasing organizations.  A significant result of this research was the identification of 
the following groups as stakeholders in this industry: 1) payers, 2) fiscal intermediaries, 3) 
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providers, 4) purchasers, and 5) producers.  Each of these groups is explained in more detail 
below.   
 Any person or organization responsible for supplying the funds to pay for medical 
expenses is identified as a payer.  Based on this definition, examples of payers would include 
government, employers, individuals and employer coalitions.  Insurance agencies, health 
maintenance organizations (HMOs), and pharmacy benefit managers fall under the category of 
financial intermediaries.  Any group supplying healthcare screening, treatment, or any other 
healthcare related provisions are considered to be providers.  Such entities would be physician 
offices, hospitals (or hospital systems), surgical centers, alternative and satellite facilities, 
ambulatory services, and pharmacies.   Individuals or groups procuring any of these services are 
viewed as purchasers; however, it is important to note that this category extends beyond the 
basic consumers of healthcare services.  This group also includes a wide variety of product 
resellers, independent distributors, pharmaceutical wholesalers, etc.  The final group is the 
producers whose responsibility is the manufacturing of healthcare products, equipment, and 
technology.  This includes pharmaceuticals, surgical equipment, information technology 
services, medical devices, and other capital equipment found throughout the healthcare system. 
Tarabusi and Vickery (1998) state that attitudes and habits of local pharmacists and 
physicians must be known for good access to markets.  This research identifies the importance of 
cost-containment programs in the pharmaceutical industry by comparing the approaches 
employed by the United States and countries of the European Union.  Globalization and 
international partnerships have grown as pharmaceutical companies strive to control the research 





2.1.2  Value Chains 
The notion of value in the healthcare service value chain can be described by the 
interrelations of relevant stakeholders.  Value chains were first introduced by Porter (1985) and 
are significant marketing tools because they afford managers the opportunity to assess the 
specific value added by each member of the supply network.  Supply chains provide a 
mechanism for delivering that value to consumers.  The original view of a value chain focused 
on a company’s internal activities specifically designed to create value for customers; however, 
this concept has been extended to include the entire product and service delivery system (Bower 
and Garda 1985; Evans and Berman 2001).   
Pitta and Laric (2004) provide a model of the healthcare value chain and supply chains as 
they exist in many practical situations.  Figure 2-1 below illustrates that this supply chain is not 
linear or sequential in nature but closely follows the flow of information through the system.  
The success or value created is linked to the transfer of quality information as the medical care 
received by patients relies heavily on information processing.   
The first two groups interacting in this network are the patients and physicians.  This 
stage of the process is generally initiated by the patient and provides valuable information 
necessary to adequately address whatever needs they might have.  This research showed that 
individuals are much more likely to share very personal information with their healthcare 
providers when they believe this information is needed for medical purposes and when they trust 
the confidential nature of the patient-doctor relationship.  The next link in the chain is created by 
the addition of pharmacists and other providers of medical equipment and services.  In this stage 
the pharmacist creates value by further investigating the medical history, specifically as it relates 
to medications, of patients to determine any potential risks or interactions that may result from 
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the addition of new, prescribed drugs.  This is a very important step in customer service and 
patient care. 
 
Figure 2-1:  Stakeholders in the Healthcare Value Chain (Pitta and Laric 2004) 
The next addition to the value chain is that of the hospital and the related services and 
procedures that may be included in diagnosing patient symptoms.  As explained by Pitta and 
Laric (2004), doctors often request batteries of tests be performed on patients even when 
symptoms and other indicators suggest a course of treatment.  Hospitals create and store vast 
amounts of medical data for patients, which can be useful going forward.  The fifth member of 
the healthcare value chain is the health insurers, which includes both public and private entities 
responsible for providing financial support to those receiving care.  Since many insurers require 
a series of diagnostic tests and related data be completed before approving potentially costly 
procedures, patient data continues to grow.  The addition of insuring groups or companies can 
also be a negative influence on the value chain.  As one can see with the addition of new 
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members to the network and the creation of data at each stage, the healthcare system and 
participant interactions are becoming more and more complex.   
Employers are the sixth group added to create another value chain.  In the United States 
(US) employers are the most often used source of medical insurance for employed persons and 
their families.  Here the value is obtained by negotiating better benefits for groups of people as 
opposed to those offered to individuals.  When the US Government introduced its Federal 
Medicare and Medicaid programs in the 1960s, it became the largest medical insurance provider 
in the United States.  A result of this involvement is the increasing influence of government 
regulation and policy in the healthcare industry.  As such, government becomes the seventh 
participant of interest here as it influences various parts of this system.  The final member of the 
model is the pharmaceutical manufacturers.  It has already been established pharmaceuticals 
represent a significant area of cost in the healthcare industry, as well as being the primary means 
of preventative and curative medical treatment. 
2.1.3  Stakeholder Conflicts 
Physicians and pharmacists/pharmacy directors clash over medications offered by the 
hospital.  The basic conflict here revolves around the issue of product variety versus economies 
of scale.  The doctors have professional and personal preferences that are reflected in their 
prescription decisions.  They value their individual freedom of choice in selecting the 
medications that they feel best address the specific needs of the patients under their care.  
Physicians are also influenced by drug manufacturers, sales representatives, and the appearance 
of new drugs in the market.  In contrast, the pharmacy directors pay more attention to the costs 
associated with specific medications and promote the usage of generic rather than brand drugs 
when available.  They strive to take advantage of economies of scale whenever possible in the 
selection of drugs offered.   
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In 2005, Prosser and Walley examined the extent to which cost influenced prescribing 
behaviors of general practitioners (GPs) in the UK healthcare system.  According to the authors, 
Primary Care Organizations (PCO) involvement has steadily increased as a means of providing 
more unified, controlled budgets for these physicians and to provide a monitoring mechanism of 
prescribing activities with this cost-containment objective in mind.  The primary goal of this 
investigation was to measure the cost-awareness of doctors and to evaluate the attitudes of these 
GPs towards cost-restraint policies.  Another goal was to determine what affect this managerial 
objective might have on their professional behavior.  In this case the evidence demonstrated that 
all of the physicians were aware of pharmaceutical costs when prescribing treatments for their 
patients and that these costs should be considered when making prescription choices.  However, 
there appeared to be a great deal of variation in the amount of influence these costs actually had 
on modifying medical decisions.  As expected, physicians identified patient care as their primary 
focus during the treatment process with cost being a secondary concern. 
Prosser and Walley (2007) continued their research in this area and employed qualitative 
methods to examine the managerial influence of healthcare administrators on the prescribing 
autonomy of general care practitioners.  In general, physician prescribing autonomy has been 
challenged recently due to the greater sophistication of patients in the ability to direct medical 
decisions and the increased bureaucratic involvement in service delivery in healthcare.  This 
research showed that the objective of cost-containment presents a formidable obstacle for 
caregivers striving to offer the highest level of care and individualized service to those they 
serve. 
The above analysis showed that managerial involvement will have limited success in 
influencing GPs’ prescribing autonomy.  The conclusion was that the GPs directly resisted the 
attempts administrators made to modify their prescribing behaviors because the GPs maintain it 
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is their responsibility to offer the best medications and treatment available to their patients and 
that this autonomy is a component of providing individual care.  In many cases this is an area of 
great conflict between doctors and hospital/pharmacy administrators since larger product 
formularies desired by doctors usually result in higher inventory costs and reduce the opportunity 
for cost savings.  When asked, doctors acknowledged the importance of controlling the costs of 
pharmaceuticals, but they identified the quality of patient care as being the paramount objective.  
Managers placed a great deal of importance on keeping prescribing costs within established 
budgets. 
Another divergence appears between hospitals and the group purchasing organization 
(GPO) on the issue of product variety.  Hospitals focus on negotiating the best prices for a wider 
selection of drugs.  The attention is shown to the brand name medications in most cases.  The 
GPO, on the other hand, strives to minimize costs in the overall system by seeking generic drugs 
as substitutes for medicines preferred by physicians.  Again, a great deal of effort is given to the 
achievement of economies of scale for demanded items by considering a limited formulary 
(narrower selection of drugs).   
The importance of product standardization for managing costs and improving clinical 
performance is outlined with respect to physicians’ unwillingness to accept products alternative 
to branded ones, even in the face of evidence regarding equivalence.   As such, hospitals persist 
in the argument for wider drug selections.  Both physician and nurse involvement and leadership 
in product analysis is necessary for successful standardization to occur and for the provision of 
metrics pertaining to products and their relationship to the performance of the supply chain. 
2.1.4  Managerial Approaches in Healthcare SCM 
In this section of the chapter, the focus shifts to the various strategic approaches that have 
been pursued in the area of supply chain management and inventory control.  Some of the topics 
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to be discussed are the outsourcing of distribution activities, allowing suppliers to manage 
inventory levels at various distribution points, and the use of common statistical techniques to 
achieve organizational and system goals.   
2.1.4.1  Outsourcing 
Kim (2005) presents an explanation of an integrated supply chain management system 
developed to specifically address issues related to pharmaceuticals in the healthcare sector.  
Many industries have recognized the importance of improved information sharing throughout the 
supply chain, and this work considers it as the most critical success factor.  Here the supply 
network is composed of pharmaceutical companies, a wholesaler, and hospitals.  The hospital’s 
operating procedures and policies were reviewed to determine system requirements in an effort 
to improve the management efficiencies of the supply chain. 
Jayaraman et al. (2000) present several tools and practical ideas to improve the flow of 
materials in a small healthcare facility. Traditional techniques, such as Pareto diagrams and 
department-product-type (DPT) matrices, were employed to track item flows and identify 
sources of errors or difficulties.  Researchers suggested several procedural and policy changes be 
implemented to reduce inventory management problems.  Landry and Beaulieu (2000) present a 
descriptive study of logistics systems at hospitals from three countries – France, Netherlands and 
The United States – to identify the best practices for replenishment policies, equipments, and 
handling technologies.  
Nicholson et al. (2004) compared the inventory costs and service levels of an internally-
managed three-echelon distribution network and contrasted it with an outsourced two-echelon 
distribution network.  Their research revealed that a general trend in healthcare is the outsourcing 
of specific organizational activities, inventory management, and materials distribution to 
“expert” third-party providers.  To this point very little attention has been given to inventory 
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management; however, changes in pharmaceutical regulations and the formation of the DRGs 
prompted a shift in approach. 
When outside entities can provide needed products or services more efficiently than 
internal departments, it can prove very rewarding.  In other instances outside providers may 
demonstrate the ability to provide the desired products or services at a higher level of quality 
than an organization may be capable of achieving (Lunn 2000).  A long-term benefit of 
outsourcing is the ability to reduce the number of suppliers in the system, which will eventually 
lower the procurement costs for the downstream members of the supply chain.  As such, the 
short-term benefits of increased efficiency and higher quality along with the long-term benefit of 
lower procurement costs make outsourcing a logical approach to overall cost containment in the 
healthcare industry and consistent with current practices in inventory management (Veral and 
Rosen 2001). 
Outsourcing decisions in this area are motivated by three factors:  the magnitude of 
investment, the impact on service quality and delivery, and the availability of qualified service 
providers.  Quality of service is arguably the paramount goal of healthcare providers (Li and 
Benton 1996), and it has been suggested that outsourcing various functions allows organizations 
to improve the quality of its internal operations.  Jarrett (1998) identified several areas in which 
providers were able to improve internal performance.  Patient care was improved, which can 
influence customer satisfaction and perceptions related to the quality of service provided by an 
organization.  As the expertise develops and the capabilities of external sources grow, 
outsourcing becomes an increasingly attractive option.  Another motivation for healthcare 
providers considering outsourcing the inventory management functions are the “success” stories 
similar to those described by Rivard-Royer et al. (2002). 
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Rivard-Royer et al. (2002) examined the changing role of distributors in the healthcare 
industry in recent years by investigating how operational processes had changed at a Quebec 
hospital  As reported by Jarrett (1998), the ever-increasing desire to control healthcare costs have 
led hospitals to re-evaluate many of their previous policies and operations.  Inventory control is a 
logical area where substantial gains can be realized.  Pharmaceuticals represent a significant cost 
equation related to both hospital inventory and quality patient care.  As such, many hospitals and 
hospital systems have focused on this specific material management issue when restraining costs.  
US pharmaceutical distributors were offering “stockless” replenishment where the distributors 
would prepackage items based on usage at individual care units and would often provide direct 
delivery of drugs to these CUs (Henning 1980).  By employing such a system the distributors 
share in the benefits and risks associated with pharmaceutical savings or costs.  The reduction in 
pharmaceutical inventory located at the hospital central pharmacy saved hospitals valuable 
resources, and the shifting of duties from the pharmacies to the distributors allowed the hospitals 
to reduce their workforce.  Another improvement was noticed in enhanced customer service.  
However, as one would expect, a critical success factor in achieving any benefits from such a 
relationship and process is the continuous exchange of information between the point of use and 
supplier (Bolton and Gordon 1991).   
2.1.4.2  Supply Coordination and Vendor Managed Inventory 
According to Rivard-Royer and colleagues (2002), by the late 1990s stockless 
replenishment was a thing of the past as hospitals sought a balance between the amount of effort 
being spent in replenishing hospital inventories and the hospitals’ inventory savings.  The 
hospital involved with this study employed a “hybrid approach” since high-demand items were 
purchased in bulk (at the case level) for delivery directly to the patient CUs from distributors and 
low-volume items were handled by the pharmacy Central Storage (CS).  For these low-demand 
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items the CS was charged with breaking-down the bulk purchases into smaller quantities for 
distribution to the various CUs as items were used.  However, this hybrid approach was found to 
have limited benefits to both the hospital and distributors.  Distributors were asked to perform 
additional work without receiving a comparable level of additional revenue.  The hospital was 
still unpacking, repacking, and preparing drugs for distribution to the CUs and failed to realize 
significant workload reductions as a result of this replenishment approach.  Overall, the gains 
were very limited in this particular study. 
One managerial shift has been to vendor managed inventory (VMI), which has been 
shown to have benefits in SCM related to enhanced material handling efficiency. Other trends in 
supply coordination have included online procurement systems and the availability of real-time 
information sharing.  These advances have demonstrated an ability to reduce total 
pharmaceutical inventory by more than 30% (Kim 2005).  In addition, the improved information 
sharing throughout the supply chain allowed for more timely and accurate inventory data, which 
resulted in better demand forecasts and materials management.   
The research of Meijboom and Obel (2007) investigated supply chain coordination in a 
global pharmaceutical organization.  The authors looked at the issues facing a pharmaceutical 
company with a multi-location and multi-stage operations structure.  Simulations are used to 
explore various coordination activities focusing specifically on “tactical control” in the firm.  
Their results suggest that a functionally organized operations structure will be unsuccessful in a 
multi-location, multi-stage environment.  According to the authors, firms can employ one of two 
methods.  They can either use a centralized approach relying heavily on information systems or 
maintain a decentralized structure that relies on transfer prices as the coordination device. 
Lapierre and Ruiz (2007) developed two modeling approaches for improving healthcare 
inventory management by examining the impact of scheduling decisions on the coordination of 
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supply activities while recognizing inventory capacities.  Specifically, the researchers 
concentrated on timing issues ranging from the purchasing and delivery of inventory to the work 
schedules and job assignments of employees.  A significant outcome of this work is the 
promotion of coordinated activities throughout the purchasing and procurement process such that 
schedules can be expanded to include more specific details for improving the resource utilization 
across the organization.  The models were tested in a hospital in Montreal, and hospital managers 
believed that the schedules generated by the models were both efficient and well balanced.  
Again, this evaluation furthered this approach as a favorable method to improving inventory 
management activities in the healthcare industry. 
2.2  Quantitative Modeling in Healthcare SCM and Inventory Control 
 One of the primary goals of our initiative is to model and improve inventory management 
practices being employed by hospitals.  There are a number of relevant inventory models in the 
current body of supply chain literature that are related to this effort, and those models are 
examined and described herein.  In this review most of the attention will focus on models 
addressing multi-item, single-location and multi-echelon coordination given the unique 
conditions germane to the industry considered.  Inventory models have been collected that have 
been formulated to address healthcare problems, have been applied, or have a high relevance to 
healthcare related inventory management.   
 After summarizing the specifics of inventory control policies and planning frameworks in 
hospital pharmacies, the demand specifics are described in this section.  A major portion of this 
section is devoted to inventory modeling; models of specific interest are multi-item, single-
location, and single-item, multi-location models.  Literature associated with each of these 




2.2.1  Inventory Control Policies and Planning Framework in Healthcare SCM 
  Efficiently managing pharmaceutical inventory systems requires another approach than a 
continuous review reorder point model. There are at least three limitations for using the 
continuous replenishment model in the context of healthcare supply systems: (a) the model does 
not account for the limited human resources, (b) it does not account for physical storage 
capacities, particularly the one at the CS level which is critical in most hospitals and (c) the 
decisions are only based on costs, not accounting for inventory control activities and their 
restricted capacity.  Each of these limitations is elaborated on below. 
 Continuous replenishment inventory management is usually not applicable in hospitals 
since visits to CUs take a lot of the employees’ time. To make it more efficient, tours are made 
such that several CUs are visited consecutively for rounds of stock control or supply distribution.  
The periodic replenishment model seems more appropriate for healthcare organizations as each 
CU is replenished according to a schedule instead of when reaching a reorder point.  However, 
with this inventory management approach, the frequencies of the visits are determined based on 
the order period and the economic order quantity (EOQ). Storage capacities at CUs and the CS 
are important factors when deciding how frequent a CU should be replenished and how frequent 
a supplier should be called.  An undersized CS and open shelves able to contain very limited 
quantities of the voluminous products is often the reality most hospitals have to face. This 
situation calls for more frequent orders to suppliers and/or keeping more stocks at the CU than 
these suggested by the EOQ model in order to satisfy requirements and respect capacities. In that 
context, CU's stocks are kept higher to compensate for a small CS. Thus, greater volumes of 
items can be stored on-site by keeping these extra quantities.  Another reason for keeping more 
stock in the overall system is that stockouts are time expensive for the supply service that needs 
to make extra emergency visits, internally referred as hot-picks, to CUs but also for the medical 
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staff who waste their time making extra calls to the supply department or chasing the products at 
other CUs. 
One of the distinct features of material management in a hospital is the use of a periodic 
review par level (or order-up to level) servicing approach. A major issue in setting par levels for 
various items in a healthcare setting is that these levels tend to reflect the desired inventory levels 
of the patient caregivers rather than the actual inventory levels needed in a department over a 
certain period (Prashant 1991). In most cases these par levels are experience-based and 
politically driven, rather than data-driven. This poses a problem for warehouse managers since 
the inventory they hold is typically based on aggregate hospital demands while requirements of 
departments when aggregated are not in line with such estimates. The literature analyzing the 
setting of optimal par levels and review periods for multiple echelons draws upon prior work in 
multi-echelon inventory systems which are discussed in the next sections. 
On the quantitative side, among one of the first healthcare inventory models was 
published by Michelon et al. (1994) who developed a tabu search algorithm for scheduling the 
distribution operations in a hospital. In their application, the number of replenishment visits is 
given a priori, and the problem consists of finding the schedule that minimizes the number of 
carriers given several time windows and practical constraints.  Another investigation 
concentrating on this type of inventory control situation was Banerjea-Brodeux et al. (1998) who 
looked at an application of a routing model to match the different CUs to be visited by a laundry 
department in a hospital.  Here the authors used a combination of quantitative techniques and 
common sense to minimize the number of routes while respecting the volume capacity constraint 
of a cart. 
Supply chain management can be fit into a planning framework. Vissers et al. (2001) 
defined a planning framework for hospitals. One of the primary objectives of this research was to 
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balance service and efficiency throughout the organization.  As identified by the investigators, 
there are three characteristics that fit hospital production control settings.  They are as follows: 
(1) a demand that is, generally speaking, larger than supply, (2) by restrictions on supply defined 
by contracting organizations, and (3) by higher patient expectations on service quality (Vissers 
et al. 2001).  As with many organizations the quandary then becomes how to maximize resources 
while still achieving higher levels of customer service.  The developed framework consists of 
five levels of planning and control:  patient planning and control, patient group planning and 
control, resources planning and control, patient volumes planning and control, and strategic 
planning (Vissers et al. 2001).  The researchers describe the framework, as well as explain 
instances where current hospital policies and practices deviate from their suggestions and where 
changes may benefit the organization. 
Another attempt is to include SCM into an Enterprise Resource Planning (ERP) 
framework. Implementation of ERP in healthcare is very challenging due to the special 
characteristics to consider. van Merode et al. (2004) explain the planning function of the hospital 
environment and identify facets of the healthcare industry that make ERP implementations and 
utilization more difficult.  Some attention is given to explaining areas in which ERP can or 
cannot be used. According to the authors, hospital functions should be divided into “a part that is 
concerned only with deterministic processes and a part that is concerned with non-deterministic 
processes” (van Merode et al. 2004).  It is their contention that the deterministic process can be 
handled very well by ERP. 
2.2.2  Demand Specifics for Hospital Pharmacy 
The usage of pharmaceutical products in hospitals has specific characteristics. Typically, 
40 to 60% are high demand items that are relatively easy to handle based on usage statistics. 
Though, much care is to be taken on the frequent changes in the used medication, on the so 
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called “formulary changes”. New items come frequently, and an initial qualitative forecast is 
required. A large proportion of the items are only rarely used, and the usage times and quantities 
are changing. Another group of items is used by patients for only a few days and finished 
afterwards. Here the auto-correlation of the demand time series is challenging to consider.  
Intermittent demand refers to the usage pattern of items that have extended time gaps 
separating irregular or sporadic periods of demand.  If the quantities of the usage are also 
variable we have the so-called “lumpy” demand that is a major challenge in pharmacy inventory 
management. The study of intermittent and lumpy demand has typically been approached from 
either a forecasting or inventory control perspective with a number of studies incorporating both 
of these areas to examine practical issues related to inventory system performance.  The body of 
work discussed in this section provides examples of this.   
Sani and Kingsman (1997) provide a good review and compare various periodic 
inventory policies like the Normal Approximation (Roberts 1962), Naddor’s Heuristic (Naddor 
1975), Power Approximation (Ehrhardt 1979), and several others.  In addition, a variety of 
forecasting methods were reviewed with the authors attempting to determine which are best for 
low and intermittent demand items. Before discussing specific inventory control approaches or 
models, it is important to recognize two fundamental notations commonly used in this literature.  
The minimum inventory parameter, or the re-order point, is commonly denoted as s while the 
maximum inventory parameter, or the order-up-to value, is represented by S.  In situations where 
item demand appears to be low or intermittent, variations of the (s, S) form of the periodic 
review inventory control system have been promoted as the optimal approach to inventory 
management. As the authors state in their review, forecasting demand for such items can also 
prove very challenging.  
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The research presented by Sani and Kingsman (1997) examines the management of spare 
parts for agricultural machinery, which includes many items with seasonal demand 
characteristics displaying vastly different demand from summer to winter months.  After 
examining the various (s, S) inventory policies with respect to annual inventory costs and 
customer service levels, the Ehrhardt’s (1979) Power Approximation proved to be a good 
inventory system for managing items with low overall demand.   This method not only scored 
well in evaluations of cost minimization but also offered reasonable service levels for items with 
low to medium demand.  From the comparisons seems that the Croston estimator (Croston 1972) 
is one simple forecasting method that performs adequately in most cases (using the exponentially 
smoothed inter-demand interval, updated only if demand occurs).  One surprising result was that 
a basic 12 month moving average of demand yielded adequate forecasting results when 
examining both annual costs and service level with exponential smoothing performing the worst 
on this measure; however, exponential smoothing performed best on the customer service level 
measure alone.  It is important to note that both of the aforementioned techniques were utilized 
along with updates every review period and the Croston forecast.  Finally, the authors concluded 
that achieving customer service levels greater that 95% for lumpy demand items is impossible 
unless high materials stocks are kept as a means to satisfy this objective. 
 Hollier et al. (2005) developed a modified (s, S) inventory model to address cost control 
issues specific to lumpy demand patterns.  This approach integrated a maximum issue quantity 
restriction and a critical inventory position as constraints influencing the inventory control 
policy.  Here the primary objective was to minimize the system replenishment costs.  These 
authors applied two algorithms, one being a tree search and the other a genetic based, to optimize 
the decision variables.  The numerical examples and results illustrate the benefits of employing 
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such algorithms, as well as, demonstrate the utility of the maximum issue quantity and critical 
inventory position constraints when managing lumpy demand items.   
Syntetos and Boylan (2006) employ simulation models to provide an evaluation of 
various forecasting techniques, specifically simple moving average, single exponential 
smoothing, Croston’s estimator, and a new technique introduced in their paper, when handling 
lumpy or intermittent demand items.  Service level and stock volume were evaluated using a 
number of performance measures related to customer service and inventory costs.  In this case 
the authors reported that the new estimator they developed outperformed other forecasting 
techniques as an inventory control method; however, it is important to recognize that the simple 
moving average technique yielded favorable results as well compared to the other two methods. 
2.2.3  Multi-item, Single-location Models for Pharmacy Inventories 
We found few papers that applied multi-item models to control healthcare inventories. 
Dellaert and van de Poel (1996) derived a simple inventory rule, a (R, s, c, S) model, for helping 
buyers at a university hospital in the Netherlands.  The notations of s and S were defined 
previously, and there meanings remain the same.  Here R represents the length of the review 
period (time between orders) while c is the can-order level.  Since most items have a joint 
supplier and the orders for a certain supplier are always placed on the same day of the week, they 
extended an EOQ model to a so-called (R, s, c, S) model, in which the values of the control 
parameters s, c and S are determined in a simplistic manner.  This approach resulted in 
substantial gains, which were observed in improved service levels, reductions in supplier orders, 
smaller total inventory levels and holding costs, and substantially lower system costs, for the 
participating hospital.   
However, we could not find other multi-item inventory applications in healthcare; we 
summarize next the models that seem to have the best application potential for this specific area. 
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The majority of results for the multi-item problem are for the deterministic demand case where 
the sizes and the multi-product sequence of orders have to be determined. The problem is known 
to be NP-complete and therefore many heuristics have been proposed. For an overview on the 
approaches, see e.g. Gallego et al. (1996), Hariga and Jackson (1996), Minner and Silver (2005).  
The early investigations in stochastic multiproduct inventory problems were generated by 
Veinott (1965), Ignall (1966), and Ignall and Veinott (1969).   Later in the study of Beyer et al. 
(2001) the researchers examined the management of multiple items with a warehousing (storage) 
constraint, which was based on the early model of Ignall and Veinott (1969), and generated 
results for finite-horizon and infinite-horizon discounted-cost problems.  This work demonstrates 
optimal policies suitable for the various conditions that occur in healthcare. 
Ohno and Ishigaki (2001) examined a continuous review inventory system for multiple 
items exhibiting compound Poisson demands and created a new algorithm for determining the 
optimal control policy.  This alternative method was derived using the policy iteration method 
(PIM) and resulted in a substantial decrease in processing time needed to evaluate and improve 
the optimal policy.  In addition, the new algorithm was tested using three joint ordering policies. 
Minner and Silver (2005) analyzed the stochastic demand, continuous review lot-size 
coordination problem for Poisson demand and negligible replenishment lead times. A 
formulation as a semi-Markov-decision-problem was presented to find the optimal replenishment 
policy and several heuristics were suggested and tested in a numerical study. However, the 
results only apply for pure Poisson demand and cycle inventories (i.e. without safety stocks). 
With the assumption of negligible lead times, safety stocks here serve to avoid the negative 
consequences of transaction sizes that exceed available inventory rather than covering against 
demand uncertainty over the replenishment lead time. 
32 
 
 In a recent paper, Minner and Siver (2007) analyze a replenishment decision problem 
where each replenishment has an associated setup cost and inventories are subject to holding 
costs. The solution of this trade-off results in order batch sizes. The warehouse space for keeping 
inventories is limited which generally restricts these batch sizes. A second aspect of their 
analysis is that demands are random, here being modeled by a compound-Poisson demand 
process. This further complicates the analysis because now, safety stocks and cycle stocks share 
the limited warehouse space. 
2.2.4  Single-item Multi-location Models - Multi-echelon Coordination in Pharmacy 
The literature analyzing the setting of optimal par levels and review periods for multiple 
echelons draws upon prior work in multi-echelon inventory systems, which is discussed next.  
One of the first investigations in the area of multi-echelon distribution networks was Allen 
(1958) who attempted to optimally redistribute stock among several locations. Since then, 
numerous works extended this model (see Simpson 1959; Krishnan and Rao 1965; Das 1975; 
Hoadley and Heyman 1977).  Another significant effort in this area was conducted by Clark and 
Scarf (1963) as it was the first study that attempted to generate and depict an optimal inventory 
policy in a multi-period, multi-echelon distribution model involving uncertain demand.  Other 
research in this area has focused on the setting of optimal lot sizes and inventory safety stocks in 
a multi-echelon supply chain (Deuermeyer and Schwarz 1981; Eppen and Schrage 1981; 
Nahmias and Smith 1994). 
 Sinha and Matta (1991) and Rogers and Tsubakitani (1991) present modeling studies in 
this research domain.  Both studies focused on two-echelon inventory systems employing 
periodic review under stochastic demand with fixed lead times.  In Rogers and Tsubakitani 
(1991), the researchers concentrated on finding the optimal par values for the lower echelon such 
that the penalty costs were minimized.  A budget value acted as a constraint of the maximum 
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inventory investment.  The optimal par level is achieved by utilizing a critical ratio, which is 
adjusted by the Lagrange multiplier subject to the budget constraint.  Sinha and Matta (1991) 
focused on minimizing the holding costs of multiple products at both echelon levels with the 
presence of penalty costs at the lower echelon.  Similarly, the results demonstrated that the 
optimal par values for the lower echelon items were obtained using a critical ratio; however, the 
holding cost function provided a method for generating the optimal values for the upper echelon. 
 Nicholson et al. (2004) extend the work of Rogers and Tsubakitani (1991) and Sinha and 
Matta (1991) by considering a three-echelon inventory system.  Specifically, this research 
concentrated on the healthcare sector and sought to compare an internally-managed three-
echelon system to an outsourced two-echelon distribution system.  Comparisons focused on 
inventory costs and service levels.  The results suggest that outsourcing the targeted functions 
yielded lower inventory costs without sacrificing customer service.  As mentioned previously, 
the use of periodic review par level servicing at the departmental level (i.e. at the individual care 
units) is a unique characteristic to hospital material management; however, it is important to note 
that the central pharmacy often operates in a similar manner utilizing another set of par values 
reflective of aggregate inventory requirements.  Zhu et al. (2005) found similar results in their 
study by using numerical simulations and sensitivity analysis of two models.  Like Nicholson et 
al. (2004), this work demonstrated cost savings with high service levels for the two-echelon 
distribution network where item demands were monitored by the distributor and delivered 
directly to the departments for use, as opposed to orders being routed through the CS as they 
would be in a three-echelon system.   
 Some models consider the case of lost sales.  Nahmias and Smith (1994) examine a two-
echelon supply chain where stockouts can penalize the retailer in cases where the customer is 
unwilling to wait for their order to be filled.  The authors assume instantaneous deliveries from 
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the warehouse to the retailer which is often not the case in practice.  Andersson and Melchiors 
(2001) executed a similar study that allowed for excess demand to be handled using backorders.  
The supply chain in this work was comprised of one warehouse with multiple retail outlets being 
serviced.  Demand here is independent Poisson processes, and lead times are considered 
constant.  The heuristic developed by the authors provides a mechanism to evaluate this type of 
supply network on elements of cost and service level. 
 Other research examining the lost sales case is that of Hill et al. (2007), which looked at 
inventory control in a single-item, two-echelon system with a continuous review policy.  Again, 
a central warehouse services several independent retailers and then has its stock replenished by 
an external supplier.  The system operates such that any excess customer demand at the retailer 
can be filled from the warehouse provided the item is in stock; however, any items which are not 
in stock result in lost sales.  Lead time for the retailer is equal to the transportation time required 
to move the item from the warehouse to the specific retail outlet.   
 The influence of order risk was examined by Seo et al. (2001) in a two-echelon 
distribution system.  They claim that the service policies should reflect the availability of real-
time stock information.  Their model adjusts the reorder time on the basis of an approximated 
order risk, which is associated with orders that are filled immediately versus those that are 
delayed.  Results show that this order risk policy performed well when warehouse lead time was 
short, where item demand was low, and where there were an intermediate number of retailers in 
the supply chain. 
 In 2003, Axsäter used an approximation technique to optimize inventory control in a two-
echelon distribution network.  Items displayed stochastic demand, and the system relied on a 
continuous review (R, Q) policy.  In this situation holding costs at all locations and backorder 
costs at the retailer were assumed to be linear.  Axsäter presents a simplified method for 
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estimating reorder points by using normal approximations for demand at both the retailer and the 
warehouse.  Lee and Wu (2006) examined a simplified two-echelon supply chain system 
comprised of one supplier and one retailer.  Here the retailer has a choice between two different 
restocking policies: traditional methods (such as an EOQ or periodic review approach) or a 
statistical process control (SPC) based method.  The results show support for the SPC method in 
addressing inventory variation issues and in reducing order backlogs.  Benefits are apparent in 
the areas of demand management and inventory control, which leads the authors to suggest this 
as alternative method for managing supply chain and inventory costs. 
2.3  Practical Solutions for Inventory Management of Pharmaceuticals in Hospitals 
The following section discusses some practical solutions to issues facing managers when 
dealing with prescription drugs.  There is a description of some dilemmas hospital personnel face 
in filling prescribed medications and the alternative methods employed to satisfy drug orders.  
Each of these solutions satisfies various needs of management; however, new concerns also arise 
with their use.  Finally, a brief overview of Multiple Criteria Decision Making is provided along 
with some approaches to decision support.  
2.3.1  Current Management Trends and Operations in Pharmacy SCM 
 Hospitals have typically employed a variety of methods and policies to resolve 
pharmaceutical inventory management issues.  A few of the more prominent solutions are 
discussed in this section to demonstrate the modern approaches seen in industry.  Specifically, 
outsourcing, VMI, and information system (IS) based solutions are presented. 
• Outsourcing 
As described in the previous literature review, outsourcing has been widely used in the 
healthcare industry.  Regardless of the specific product, entering into partnerships with suppliers 
and distributors for the purposes of combining services have generated benefits for the healthcare 
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providers (see Nicholson et al. 2004; Veral and Rosen 2001; Lunn 2000; Jarrett 1998; Li and 
Benton 1996, etc.).  The magnitude of resources linked to pharmaceutical inventory and its 
management, the desire to shift or reduce pharmacy workloads, and the opportunity to refocus 
resources on patient care make this an appealing proposition for healthcare providers.  However, 
as shown by Rivard-Royer et al. (2002), all parties must benefit from such arrangements to 
provide long-term gains. 
• VMI 
Another trend is the growing usage of VMI strategies (Kim 2005).  This a specific type of 
outsourcing in which pharmaceutical inventories located at various distribution locations (i.e. at 
the CUs) around the hospital are monitored by the supplier, in this case the pharmaceutical 
company or distributor, and replenished as needed.  Currently, several hospitals employ a 
continuous review (s, S) inventory control policy.  When demand for an item reaches a pre-
determined minimum level (s), an order is automatically generated and transmitted directly to the 
supplier.  The supplier, in turn, ships the amount necessary to refill the distribution centers to the 
maximum quantity (S).  Depending on the specific circumstances, materials can be either sent to 
the pharmacy for re-packing and distribution or sent directly to the point-of-service, which 
bypasses the pharmacy entirely.   
• IT-based Inventory Management Solutions 
Information systems play a significant role in all of the aforementioned suggested 
approaches; however, they are perhaps even more critical in the next solution.  Perini and 
Vermeulen Jr. (1994) reviewed a number of devices focused on the dispensation of medicines 
located around the hospital in the patient care unit (i.e. Lionville CDModule, Meditrol, Argus, 
MedStation™, Sure-Med, and Selectrac-Rx) with the purpose of replacing the traditional dosage 
carts used by pharmacies and to shift control of locally-stored pharmaceutical inventories and 
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controlled substances to caregivers at the point of use.  Inventory stored in the CUs offer 
caregivers the opportunity to dispense medications quickly to patients; however, restocking these 
units can take extra time.   
These medication-management machines are designed to offer financial and practical 
advantages over traditional operating procedures where inventories are stored in a central 
pharmacy and then distributed by dose carts as needed.  Another benefit of using these local 
devices is the ability to quickly create, store, and access point-of-service patient information, 
which can also expedite the documentation requirements associated with drugs.  The technology 
employed by these solutions enhances operating efficiency and facilitates customer care by 
lowering the risk of patients receiving incorrect medications.  Regardless of the specific solution, 
these systems usually offer pharmaceutical administrators the ability to reduce inventory 
carrying and other costs, to improve billing and usage information, and to increase staff 
productivity by creating a highly-integrated, data-driven information flow.   
2.3.2  Multiple Criteria Decision Making (MCDM) 
The International Society on Multiple Criteria Decision Making (ISMCDM) has defined 
MCDM as “the study of methods and procedures by which concerns about multiple conflicting 
criteria can be formally incorporated into the management planning process” (ISMCDM 2008).  
Here “solving” a problem is associated with selecting the “best” alternative from a set of 
available and viable solutions.  The best solution is the one that most closely satisfies managerial 
goals given the decision makers preferences in objectives.   
Given the complexity of most business operations, this is an active area of research that 
serves as a foundation for decision support system development.  In this field there are two types 
of problems:  1) multiple criteria evaluation problems and 2) multiple criteria mathematical 
programming (MCMP) problems.  Multiple criteria evaluation is appropriate when there are a 
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finite number of alternatives that are explicitly known in the beginning of the solution process.  
For MCMP the number of alternatives is infinite and not countable, and these alternatives are 
usually determined using mathematical models.  These alternative solutions are only implicitly 
known as well. 
There are several methods employed to achieve optimization in MCDM.  First, when 
there is a single decision maker (DM), a rating method can be used such that each criterion is 
rated on a scale of 1 to 10.  The results are normalized to obtain weights for each criterion.  
Another common procedure is to use one of two ranking methods.  The first ranking method is 
that of paired comparisons of criteria in which the decision maker is asked for preference 
information between various pairs of criteria.  For example, decision makers are asked to identify 
if criterion A is preferred to criterion B, if B is preferred to A, or if they are indifferent in the 
choice.  However, there could be a problem with the consistency of preferences.  There is a 
method known as LINMAP developed by Srinivasan and Shocker (1973) that provides for the 
comparison of alternatives to determine the optimal weights.  The process is designed to 
determine the optimal weights that will minimize the error or inconsistency in the decision 
maker’s preference responses.  Other methods involve various scaling methods such as simple 
scaling, linear scaling, vector scaling using linear programming norms, linear programming 
metrics, and using a combination of ideal solution and linear programming metrics.   
Beyond these processes for establishing weights for the various criteria in problem 
optimization, there are several approaches for determining the optimal solutions of these 
problems.  Methods that do not include any knowledge of the decision maker’s preferences are 
global criterion and compromise programming (Yu and Zeleny 1975).  Goal programming relies 
on pre-specified preferences and attempts to minimize the sum of the weighted deviations from 
the goals set for each criterion.  Problems here would employ linear goal programming (LGP), 
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partitioning algorithms for goal programs (Arthur and Ravindran 1978, 1980), integer goal 
programming (Arthur and Ravindran 1980), nonlinear goal programming (Saber and Ravindran 
1993, 1996), and intelligent search methods (Kuriger and Ravindran 2005).  
40 
 
CHAPTER 3:  RESEARCH ENVIRONMENT AND METHODS 
 In this chapter, attention is given to the research problems and the methodologies 
employed to address these issues.  The traditional supply and inventory control operations of 
hospitals around the world were presented earlier in this dissertation.  Here an overview of the 
specific research environment is provided, as well as, some details about the IT-based, inventory 
management solution currently utilized by both this local hospital and many others.  In addition, 
there are a number of quantitative and managerial challenges that are readily observed and 
expressed by hospital administrators.  The focus of this research is to address these issues and 
provide quantitative models of varying complexity and differing data requirements that can be 
implemented for improving the operational, tactical, and strategic managerial decision making. 
3.1  The Supply Chain and the Major Decisions of the Hospital Pharmacy 
 The basic structure of the supply network of the case hospital includes 
• within the hospital 
o customers (doctors,  nurses, patients), 
o local depots (Pyxis MedStations® at 86 different locations), and a 
o central depot ( Tallyst® system at one location); 
• outside the hospital 
o wholesaler (Cardinal GPO, one basic supplier) and 
o producers (around six major pharmaceutical companies selected by GPO). 
 
The hospital applies advanced technology in controlling medication throughout the hospital. 
The drugs are stored in the local depots (Pyxis MedStations®) in 86 different areas of the 
hospital. Each area has a different selection of drugs. The Pyxis MedStation® registers each 
transaction date and quantity of demand (withdrawal) and each delivery (refill) and the actual 
inventory level. It is connected to the central depot (Tallyst® system) through a computer 
network. 
As the inventory level decreases to the reorder point (min par level) an automatic order is 
triggered by the local depot. The order quantity is determined by the order up to level (max par 
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level). The par levels can be selected and fixed for each drug. Currently, the par levels are based 
on fixed day-supplies suggested by the supplier GPO. These values are corrected occasionally by 
the local pharmacists using so-called “experiences”; however, no modeling or optimization is 
involved in setting these control values. 
The demand for each drug is uncertain. The daily usage data is available for each drug 
and each local depot for the period of two years. In the drug supply a high service level is 
essential. In case of a shortage at a local depot (Pyxis®), an emergency delivery is necessary, and 
this emergency refill is very costly. 
The central depot (Tallyst®) must satisfy the orders of the local depots within a day.  One 
major goal of the hospital pharmacy is to minimize the number of refills (drugs per location) per 
day.  If the number of refills per day is very large, it cannot be done in two shifts and to have 
overtime or an extra shift is difficult and costly.  Shortage in the central depot is rare and in that 
case the wholesaler (GPO) refills within a day.  The inventory holding cost factor is not a major 
concern for the hospital because the wholesaler is financing it. However, inventory holding cost 
is included later and in an effort to examine the effect of its consideration. 
The physical volume (the total space) of the Pyxis® system is limited.  It consists of 
drawers. Each drawer is subdivided by spacers that can be relocated so different cubicles are 
constructed and assigned to each drug.  Different drugs cannot be stored in the same cubicle.  
The total room for the cubicles is fixed. 
The main goals of the management are:  
• provide a high service level for each drug, 
• minimize the total number of expected refills (orders) per day for a Pyxis®, and 
• use the limited space of a local depot (Pyxis®) in the best way by subdividing it to 
separate areas (cubicles) for each drug. 
The decision variables are the reorder point (the min par level) and the order up level (max par 
level) for each drug.  The average daily demand and the standard deviation of the daily demand 
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can be calculated from historical data.  Also, we know the storage space requirement for a unit of 
each drug and the maximum storage space in a Pyxis®. 
The operational decision problems occur on the item level:  How to set the min and max 
par levels for each (250 to 300) drug in each one of the 86 Pyxis MedStations®?  
-   In setting the reorder point (min par level, si) there is a major tradeoff:  
• increase si since in case of shortage a high emergency refill cost occurs which requires the 
provision of a high service level;  
• decrease si since it needs additional buffer inventory that takes space from cycle stock and 
consequently more frequent orders and higher refilling cost arise; refilling cost rather the 
inventory holding cost is the primary concern for the hospital.  
-  In setting the order up level (max par level, Si) the major tradeoff: 
• increase Si to maximize cycle stock so that less frequent orders decrease the refilling cost;   
• decrease Si because of the limited space for total inventory in a Pyxis MedStation® 
There is also a connection between safety and cycle stock (si and Si) for each drug, so it 
necessitates the joint consideration of si and Si.  
 On the other hand, there is a tradeoff among the different drugs in a Pyxis® because of 
the total space limitation. Thus, the tactical decision problem occurs at the multi-item level:  
How to allocate the space (by flexible drawer dividers) among the 250 to 300 drugs in each 
Pyxis®? What is the best allocation strategy for safety and cycle stock?  How to set the si and Si 
control parameters according to the allocation strategy? These questions indicate various 
tradeoffs to consider among the different drugs in a Pyxis®. Further requirements include: 
• The limited space is subdivided to separate areas (cubicles) for each drug.  
• The cubicles cannot be shared among drugs.  
• The max inventory level (Si) must fit into the assigned cubicle. 
 
The major strategic decision problems include: What kind of tradeoffs are among refill 
workload, emergency workload, and variety of drugs offered (formulary)? What are their 




In the subsequent portions we provide quantitative models, approximations and solutions 
starting with the operational decision problems and discuss the applicability and managerial 
implications of our models for tactical and strategic decisions in the hospital pharmacy. 
3.2  Quantitative Models for the Hospital Inventory Management 
 This portion of the work presents three quantitative models examined in this 
investigation.  In addition, a number of iterative processes are utilized to determine the optimal 
inventory control parameters given the goals of the individual models and the various 
constraints.  The notations, models, and the solution processes are identified here. 
3.2.1  Model 1:  A General Multi-product (s, S) Model with Space Constraint and Its 
Approximation 
 
The ultimate goal of the hospital pharmacy operation is to find the optimal values of the decision 
variables 
- si : the reorder point (the min par level) and 
- Si: the reorder level (max par level or order up to level) for each drug i (i = 1 to n)  
to minimize the total expected refilling (ordering), inventory holding and shortage cost under 
volume constraint of the local depots.  The total space is subdivided into separated and dedicated 
storage areas for each drug, and they must be large enough to hold the max par level for each 
drug. The cost factors for item i are 
 Ki : cost of a refill (order), 
 hi = r ci: holding cost for a drug with value of ci , and 
 pi: shortage cost of an emergency refill that is independent of the size of the shortage.  
The optimization problem can be formally expressed in  
 
Model 1: 
  Min      ∑ [Ki Ni(si, Si) + hi Hi(si, Si) + pi Pi(si, Si)]    (1) 
  




with the notation for each item  
 Ni(si, Si) = the expected number of orders per period, 
 Hi(si, Si) = the expected inventory per period, 
 Pi(si, Si) = the probability of shortage per period, 
 vi = volume requirement for a unit, 
 M’ = total volume of the space available for the n items. 
 Scarf (1963) expressed the above expected values, Ni(si, Si) and Hi(si, Si), using renewal 
functions. The probability of a shortage in a period has been derived by Schneider et al. (1995) 
using the steady state distribution of inventory on hand plus on order published in Iglehart 
(1963).  Since these expressions use the renewal equation, it is only possible to get the exact 
solution for the single-item case with specific demand distributions.  A further problem, as it was 
shown by Wagner et al. (1965), that the cost function, even for a single item, is not convex.  
Thus, following the traditional constrained optimization solution for Model 1 using the 
derivatives of the Lagrangian with respect to the parameters si and Si, setting them equal to zero 
and solving the equations will not necessarily provide the optimum.  However, the Roberts 
(1962) approximation based on the first derivatives of the Lagrangian produces nearly optimal 
solution for a single item cost function.  Schneider and Rinks (1989) suggested an approximate 
solution for a constrained multi-item problem similar to Model 1, based on the Roberts (1962) 
approximation, and by employing a search algorithm they verify the approximate optimality of 
the derived policy.  This procedure can also be applied as a benchmark in our case, but it is too 
cumbersome for our practical application.  
 There is a stream of publications handling hospital supply problems with some 
similarities to our case and another stream of papers handling similar multi-item constrained 
problems with no reference to hospital management.  The publications in both streams closest to 
this situation are listed next.  
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Michelon et al. (1994) published a tabu search method to optimize the distribution of 
supplies in a hospital.  Dellaert and van de Poel (1996) derived a simple inventory rule for joint 
ordering in a university hospital in the Netherlands.  Banerjea-Brodeur et al. (1998) looked at an 
application of a routing model to match the different care units to be visited by a laundry 
department in a hospital.  Vendor managed inventory (VMI) has been applied in healthcare since 
the nineties.  An analysis and the hospital saving potentials of VMI are demonstrated in Kim 
(2005).  Meijboom and Obel (2007) investigated supply chain coordination facing a 
pharmaceutical company with a multi-location and multi-stage operations structure.  They 
concentrated on the organizational issues.  Lapierre and Ruiz (2007) developed modeling 
approaches for improving healthcare inventory management by examining the impact of 
scheduling decisions on the coordination of supply activities while recognizing inventory 
capacities.   
Ordering policies for multi-item inventory systems subject to multiple resource 
constraints considering deterministic demand were published in Güder and Zydiak (1999). A 
stochastic multi-item constrained model is discussed by Beyer et al. (2001) but only for the case 
of base stock policy.  Ohno and Ishigaki (2001) examined a continuous review inventory system 
for multiple items with compound Poisson demands.  Here the joint ordering was targeted but no 
space or budget constraints were considered.  Minner and Silver (2005) analyzed the stochastic 
demand, continuous review lot-size coordination problem without safety stock consideration.  In 
a recent paper, Minner and Silver (2007) analyze a replenishment decision problem where each 
replenishment has an associated setup cost and inventories are subject to holding costs.  A 
second aspect of their analysis is that demands are random, here being modeled by a compound-
Poisson demand process.  This further complicates the analysis because safety stocks and cycle 
stocks share the limited warehouse space. 
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In summary, the published papers handle several aspects of this research case; however, 
they fail to consider jointly the challenge of multi-item and joint constraint with demand 
uncertainty or are too complex, time and data intensive for our practical application.  
 As such, another approach is taken to provide a faster approximate solution of Model 1.  
The model is simplified by applying straightforward first order approximation for the objective 
function (1) and the constraint (2). Consider 
 L = lead time (in our practical case it is one period), and use the additional notation for 
item i 
 Di = Si –si, 
 Qi = expected order quantity, 
 di = expected demand per period, 
 σi = standard deviation of the demand per period, 
 ui = undershoot quantity, expected inventory position below si when an order is placed. It 
can be approximated by the first two moments of the demand per period in the form (see 
Schneider 1981) 
  
ui ≈ ui(di, σi)  = (di2 + σi2)/2di          (3) 
Using this approximation, we can express the expected order quantity as function of di and σi: 
 Qi ≈ Qi(di, σi) = Di + (di2 + σi2)/2di          (4) 
Thus we have the following simple approximate expressions as functions of di and σi: 
 Ni(si, Si) ≈ di / Qi(di, σi)         (5) 
 Hi(si, Si) ≈ si - ui(di, σi)  - Ldi + Qi(di, σi) /2      (6) 
The probability of a shortage in a period can be approximated (see in Schneider et al., 1995)   




x s f x L dx
∞
− +∫ /Qi      (7) 
where 
  fi (x|L+1) is the demand density function for a period of length L+1. 
 The solution of Model 1 using approximations (4) to (7) is more straightforward, and it 
could be applied to check different practical scenarios in our case.  However, the managerial 
problem is that the ordering and shortage cost factors are very difficult to provide.  The technical 
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problem is that the large number of items (n=250 to 300 per local depot), the nonlinearity, and 
the stochastic demand make the solution challenging and time consuming.  
 The current control levels suggested by the distributor of the Pyxis MedStations® 
and by the pharmacy supplier (GPO) is a fixed day-supply, Tmin and Tmax policy, using si = di 
*Tmin and Si = di *Tmax , independently from the demand variability or storage space requirement.  
This simplistic policy results in frequent shortages and emergency refills for some drugs and also 
a large number of regular refills putting an overload and/or overtimes for the pharmacy staff.  
Additionally, storage space problems occur frequently.  Based on experiences the pharmacists 
are frequently modifying the fixed day-supply policy, but there is a need for appropriate decision 
support in how to modify the si and Si control parameters.  To resolve those high priority 
problems, a simplified optimization model was formulated concentrating on the key goals. 
 The changing composition of the drugs stored (formulary) and the dynamic demand 
characteristics call for a fast solution on the daily operational level.  The two different simplified 
models and simple approximate solutions we provide in the next two sections are also 
advantageous to provide efficient tactical decision support in managerial tradeoffs and in 
allocation strategies for safety and cycle stock.  Further, for strategic decisions, the simplified 
models provide easy-to-handle tools.  First, in Model 2 consideration is given to both ordering 
(refill) and holding cost under service level constraint.  In the subsequent Model 3, the 
concentration is only on ordering (refill) cost minimization under service level constraint.  In 
both models the space limit constraint is also included.  The simple solutions enable using Excel 
spreadsheets that are familiar and easy to interpret by the pharmacists controlling the system.  
3.2.2  Model 2:  Optimal Allocation Based on Ordering and Holding Costs 
 In the inventory management literature the difficulty of providing the appropriate cost 
factors is well known, especially the shortage cost is hard to quantify.  This is valid also in our 
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pharmacy case, so we follow the common practice and consider a service level constraint instead 
of shortage cost in the next two models.  Since the shortage means an emergency refill in our 
case with a fixed cost (depending only on the number of shortage occasions per days and not on 
the amount of the shortage) it is appropriate to consider the so-called α service level which is the 
chance that there is no shortage in a period (day).  Using this service level Model 1 can be 
modified and simplified into the following form. 
 Minimize the total refills (orders) cost plus the inventory holding cost for a Pyxis®, 
subject to the constraints: 
- the service level (chance of no shortage) for each drug is high (at least α),  
- the total space needed for the maximum possible inventory level for all drugs is not more 
than the available total space of the Pyxis MedStation® (M’). 
 
 Using the notation, expressions and approximations (3) to (6) from the previous section, 
we can formulate  
 
Model 2: 
Min  ∑ �Ki
di
Qi
+  hiHi(si, Si)�      (8) 
  s.t.  
   Prob (shortage for drug i) ≤ 1-α,  (i = 1 to n)   (9) 
∑ (vi Si ) ≤ M’        (10) 
 The solution of Model 2 is still quite complex because of the several variables, the 
nonlinearity and the stochastic constraints. To simplify the solution, we consider the two types of 
constraints, service level (9) and space (10) constraints, separately and also the two sets of 
decision variables (si and Si) separately and solve the optimization Model 2 iteratively, using 
Power Approximation for handling the service level.  
 An iterative solution is applied based on two embedded iteration procedures for the 
optimization of Model 2. The specific Power Approximation formula derived in Schneider 
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(1978) provides a good approximation of the reorder points, si, providing the required service 
level α.     
 
si =  di(Li + 1) + p(yi)σi,Li+1 −
δ(σi
2/di−1) (−1.95269 + 6.39059yi )
(1 + 21.17036 yi )
   (11)  
 
with δ(x) = max (x, 0) and p(yi) being a rational function of yi, where yi 
 
 yi =  
(1−α)Qi
�σi ,L i +1
2
          (12) 
 
depends on the service level, α, and also on the Qi values.  
 To initialize the iteration, we first set the value of the expected order quantity Qi using the 
Economic Order Quantity (EOQ) formula, which is noted as Qi'.   
  Qi ′ =  �
2di Ki
hi
        (13) 
Using the above Qi’ values and the fixed service level α we calculate the appropriate si = si(0) 
values from Power Approximation (11).  The resulting decision variables provide the 
approximate optimal solution of Model 2 if the space constraint (10) is fulfilled.  Using the 
notation of the previous section we get  
  Si = si + Di = si + Qi - ui       (14) 
for the optimal parameters. In the case the approximate optimal par levels, si, Si, (i=1,…,n) are 
provided by  si = si(0), and (14) using the approximation (3) for the expected undershoot 
quantities, ui. 
 If the space constraint (10) is not fulfilled, the above solution is not feasible. That means 
the equation  
  ∑ (vi Qi )  ≤  M’ - ∑ [vi (si- ui)]       (15) 
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is not fulfilled, and there is a need to decrease the Qi values so that the required storage space for 
order quantities ∑ (vi Qi ) such that there is less than the remaining total free space for cycle 
stock 
  M = M (si)  = M’ - ∑ [vi (si - ui)]       (16) 
 To find the optimal Qi values that fit into the remaining space, M, defined by (16) we 
formulate the sub-problem  of minimizing the ordering and cycle stock inventory holding cost 
under the remaining total free storage space. In this sub-problem, we fixe the reorder points, si  = 
si(0) and the resulting M = M0 expressed in (16) using si = si(0).  
Sub- problem 2A: 






�        (17) 
s.t. ∑ viQi  ≤ M         (18) 
 This sub-problem 2A cannot be solved directly, but the iterative solution procedure 
suggested by Ziegler (1982) can be applied. 
 To initialize the iteration, we use the Economic Order Quantities (EOQ), noted before by 
Qi', which also provides the upper bounds, Q(u), on the order quantities for the iteration. 
The overall volume of using these Q values is 
 V′ =  ∑ viQi′           (19) 
Here we have the decision rule as described before, if V' ≤ M, stop.  Otherwise, go to step 1 of 
the iterative solution. 
In the first iteration step we calculate the lower bound, Q(l), in the form Qi", as  
 Qi" =  
M
V ′
Qi ′          (20) 
and calculate values for λi,  for i = 1, …, n, where 





         (21) 
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Once the values of λi have been calculated, set λ' = min λi and λ" = max λi.   
 In the second iteration step, average the min and max values as determined in step one 
to set the overall λ. 
 λ =  λ
′+ λ′′
2
           (22) 
 In the third iteration step, we calculate a new Qi using the λ provided in step two, which 
is noted as Qi(λ) for i = 1, …, n. 




           (23) 
and recalculate V using (19) and substituting the new Qi(λ) for the original Qi.  Next, employ the 
following decision rules. 
 If V< M, then set λ" = λ and Q(u) = Qi(λ). 
 If V> M, then set λ' = λ and Q(l) = Qi(λ). 
In the fourth iteration step, calculate the functions for the upper and lower bounds as 
 F�Q(u)� =  ∑ �Ki
di
Qi




�       (24) 
 F�Q(l)� =  ∑�Ki
di
Qi




�       (25) 




 ≤ E         (26) 
If the relative difference is determined to be less than or equal to the preset acceptable 
error, which was 0.01 in our case, stop.  Otherwise, continue the iteration beginning at step two 
and repeat this process until convergence.   Once the optimal Qi values are obtained, move to the 
second stage of the iterative solution and use these Qi values to adjust the reorder points and find 
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the si values providing the required service level, α, for each item.   With the new si = si(2), we 
recalculate M = M2 and solve the sub-problem 2A again with the iteration process above.  The 
resulting Qi values may be different than those determined in the prior step in which case new si 
= si(3) values are used for new iterations until the difference in si and Qi is smaller than the preset 
accuracy limit (E = 0.01).  The proof of the convergence of the above iterative procedure is in 
Ziegler (1982). 
3.2.3  Model 3:  Optimal Allocation Based on Ordering Cost  
  In this practical case, the major goal of the hospital pharmacy is to minimize the refill 
workload.  Inventory holding cost is marginal and is not even considered currently in the Pyxis® 
database.  This is motivation to simplify Model 2 and provide a simple, goal-oriented decision 
support tool for the pharmacy management.  So, next consider the simplified constrained 
optimization problem. 
 Minimize the total number of expected refills (orders) per day for a Pyxis®, subject to the 
constraints: 
- the service level (chance of no shortage) for each drug is high (at least α), and  
- the total space needed for the maximum possible inventory level for all drugs is not more 
than the available total space of the Pyxis MedStation® (M’). 
 
Model 3: 
Min  ∑ (di / Qi)       (27) 
  s.t.  
   Prob (shortage for drug i) ≤ 1-α,  (i = 1 to n)   (28) 
∑ (vi Si ) ≤ M’        (29) 
 Despite the objective function of Model 3 being simpler when compared to Model 2, we 
still have the problem of having the same large number of decision variables, as well as, the 
nonlinearity and stochastic constraints as before.  As such, a similar iterative solution is applied, 
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but it proves to be faster and easier to interpret than optimization Model 2.  Here we also 
consider the two constraints, service level (28) and space (29) constraints, separately and also the 
two sets of decision variables (si and Si) separately and solve the optimization Model 3 
iteratively, using the same Power Approximation as before for handling the service level. This 
method is very straightforward, intuitive and sheds light on the simple structure of the optimal 
allocation of the safety stock and cycle stock separately. 
 To initialize the iteration, set the reorder point  
 si(0) = di *Tmin,          (30) 
as it is suggested by the pharmacy supplier.  Thus 
 M0 = M0 (si(0))  = M’ - ∑ [vi (si(0) - ui)]       (31) 
is the remaining total free storage space for order quantities. 
 To find the optimal Qi values we formulate the sub-problem of minimizing the number of 
orders per day under the remaining total free storage space for cycle stock with fixed reorder 
points, si(0) and the resulting M = M0 expressed in (31): 
 Min  ∑ (di / Qi)         (32) 
s.t.  
 ∑ (vi Qi) ≤ M          (33) 
Proposition 1:  The optimal space allocation for Qi to minimize the expected number of orders 
is proportional with the square root of the demand over volume rate, and the optimal 
solution of (32) s.t. (33) is 
   Qi (0) = M/W * √ (di /vi)      (34) 
with notation 
   W = ∑√ (vi di)        (35) 
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Proof:  Considering the Kuhn-Tucker conditions for the Lagrange function of Model 2 
  L(x, λ) = ∑ (di / xi) + λ [∑ (vi xi) - M]     (36) 
for the optimal x*i and  λ* 
  x*i ∂L(x*, λ*)/∂ xi  = - di / xi + λ* vi xi  = 0  for i = 1,...,n   (37) 
so if λ* is known from (37) we get  
  x*i = √ (di / λ*vi)          (38) 
On the other hand, if any of x*i is known  
  λ* = di / (vi x*i2)        (39) 
Since for the optimal solution the capacity constraint is active 
  ∑ (vi x*i) = M         (40) 
Substituting (38) into equation (40) and using the notation 
  W = ∑√ (vi di)         (41) 
the optimal value of λ* can be expressed  
  λ* = (W / M)2         (42) 
and substituting  (42) into (38) provides for i = 1,…, n the optimal  
  x*i = √ (di / λ*vi)  = [M √ di ] / [W√ vi] = M/W  √ (di/vi)   (43) 
 In the first iteration step adjust the reorder points and find the si(1) values that provide 
the required service level, α, for each item.  Here the simple Power Approximation formula 
derived in Schneider (1978) expressed in (11) and (12) is employed. 
 The modified si(1) values will change the available space for cycle stock according to 
   M1 = M1 (si(1))  = M’ - ∑ [vi (si(1) - ui)]     (44)  
which provide the next iteration of  
  Qi (1) = M1/W * √ (di /vi)       (45) 
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The iteration for si(2) results from Power Approximation (11) and (12) applying Qi = Qi(1).  
Continue the iterations until convergence.  According to formula (11), there is a minor effect of 
Qi on si, thus the convergence is very rapid; by our experiences two-three iterations are sufficient 
to get within 0.1% range.  
 The approximate optimal control parameters for item i (i = 1 to n) are  
• min par level, si, is the last iteration expressed in (32) and (33) ; 
• max par level, Si , is resulting from the last iteration (34) for  M 
 Si = si + Di         (46) 
using the approximation with expression (31) for W 
 Di =  
M
W




2di          (47)
 
3.3  Comparison of Optimization Efforts for Model 2 and Model 3 
In this section we examine the efforts required to achieve the optimal order quantities, Qi, 
for the multi-item case using the sample of 70 items in a Pyxis®.  First, Model 2 examples are 
presented to show the changes in iterations that occur as the optimal order quantities are reached.  
Second, an illustration of Model 3 is presented to demonstrate the simplicity of calculations and 
the quick nature of optimization using this approach.  This is done to contrast these techniques, 
as well as, to show the steps and efforts necessary to complete the iterative processes. 
3.3.1  Demonstration of Model 2 
 Model 2 involves a multi-iteration, multi-round process to achieve optimization.  The 
specifics of the model and this process are presented in Chapter 3.  Here we see the precise 
results obtained as the iterations progress.  Model 2 required several rounds iterations with a 
number of iterations within each round.  Specifically, 2 rounds of iterations were required with 
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11 iterations necessary in both rounds to achieve convergence.  The results below reflect 
outcomes of final round of iterations, which ultimately provide the optimal Qi values with the 
required accuracy. 
 To begin the iterative process a comparison must be made between the M value provided 
by Model 3 and the overall volume, V, required to house the items in the sample.  As shown in 
Table 3-1, the space required was determined to be 17874.59 and exceeds our initial M1 value of 
4859.79, which prompted the start of the iterative process.  With each step of the iteration, the V 
is adjusted by the Qi values determined in the previous step in an effort to minimize the 
difference between the space needed and the space available, M.  The magnitude of these 
corrections are very large early on in the process because of the tremendous discrepancy between 
V’ and M1, but this volatility diminishes as optimization is achieved. 
Table 3-1:  Changes in Overall Volume 
 
Value % Change 
V' 17874.59 --- 
V0 757.39 -2260.01% 
V1 1063.28 28.77% 
V2 1484.05 28.35% 
V3 2052.61 27.70% 
V4 2801.62 26.73% 
V5 3753.19 25.35% 
V6 4898.67 23.38% 
V7 4207.27 -16.43% 
V8 4511.35 6.74% 
V9 4692.29 3.86% 
V10 4791.93 2.08% 
V11 4844.36 1.08% 
 
The values of V shown in Table 3-1 are changed by constantly adjusting the lambda, λ, values 




Table 3-2:  Values of Lambda  
 
Values of λ 
 
λ' λ" λ 
Initial 0.005 5.980 2.993 
Iteration 1 0.005 2.993 1.499 
Iteration 2 0.005 1.499 0.752 
Iteration 3 0.005 0.752 0.379 
Iteration 4 0.005 0.379 0.192 
Iteration 5 0.005 0.192 0.099 
Iteration 6 0.005 0.099 0.052 
Iteration 7 0.052 0.099 0.075 
Iteration 8 0.052 0.075 0.064 
Iteration 9 0.052 0.064 0.058 
Iteration 10 0.052 0.058 0.055 
Iteration 11 0.052 0.055 0.054 
 
 As explained, the upper and lower bounds of Qi are adjusted with each iterative step.  
Table 3-3 summarizes the average percent changes in Qi observed across all items in the sample.  
In this case the upper bound of Q was corrected between 24% and 29% in each of the first five 
iterative steps.  At that point the value of V, as shown in Table 3-1, prompted an adjustment of 
the lower bound by 23%.  In steps 7 through 11, the corrections shifted back to the upper bound.  
At that point, the iterations were halted as a result of the stopping rule. 
Table 3-3:  Average Percent Change in Q with Iteration 
 
Q' = QU Q" = QL 
Step 0 --- --- 
Step 1 29% 0% 
Step 2 28% 0% 
Step 3 27% 0% 
Step 4 26% 0% 
Step 5 24% 0% 
Step 6 0% 23% 
Step 7 10% 0% 
Step 8 6% 0% 
Step 9 3% 0% 
Step 10 2% 0% 




To further illustrate this process an example is provided at the item-level.  The drug with 
the highest daily demand was selected to demonstrate the convergence to the optimal order 
quantity for that item.  This is shown in Figure 3-1. 
 
Figure 3-1:  Convergence to the Optimal Q for a Sample Drug 
The specific results for this drug are provided in Table 3-4.  This table supplies both the 
upper and lower bounds of Q throughout the iterative process and the observed percentage of 
change resulting from each step.  As expected, the pattern is similar to that presented in  
Table 3-3. 
As described earlier in this chapter, the stopping rule for the iterations within each round 
is set such that the percent difference between the objective functions of the upper and lower 
bounds of Q must be below a preset error.  Here the iterations were halted when the error was 
less than 1% (i.e. 0.01).  Table 3-5 displays the results from the actual iterations in Round 2.  As 
shown, the convergence is reached by individually adjusting the upper or lower bounds as 
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dictated by the procedure.  Gradually, as the iteration evolves, these functions migrate until the 
difference is small enough to satisfy our stopping rule. 
Table 3-4:  Optimization of Q for a Sample Drug 
 
Q' = QU Q" = QL QU % Change QL % Change 
Step 0 16.66 144.34 --- --- 
Step 1 23.53 144.34 29% 0% 
Step 2 33.19 144.34 29% 0% 
Step 3 46.67 144.34 29% 0% 
Step 4 65.29 144.34 29% 0% 
Step 5 90.41 144.34 28% 0% 
Step 6 90.41 122.90 0% -17% 
Step 7 103.00 122.89 12% 0% 
Step 8 111.64 122.89 8% 0% 
Step 9 116.86 122.89 4% 0% 
Step 10 119.77 122.89 2% 0% 
Step 11 121.30 122.89 1% 0% 
 
Table 3-5:  Functions of Q for Model 2 Iterations 
 
F(QU) F(QL) Difference 
Initial 2332.92 775.42 200.86% 
Iteration 1 1684.32 775.42 117.21% 
Iteration 2 1236.70 775.42 59.49% 
Iteration 3 932.38 775.42 20.24% 
Iteration 4 729.55 775.42 -5.92% 
Iteration 5 597.80 775.42 -22.91% 
Iteration 6 597.82 515.10 16.06% 
Iteration 7 558.56 515.12 8.43% 
Iteration 8 537.45 515.12 4.34% 
Iteration 9 526.45 515.12 2.20% 
Iteration 10 520.82 515.12 1.11% 
Iteration 11 517.97 515.12 0.55% 
 
This process is performed during each round of the iterative process.  After the first 
round, the final Qi (Qi = QL) are used in the Power Approximation formula (11) to calculate the 
corresponding reorder points, si, for each item in the sample.  These new si values allow for a 
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new M1 value to be established, which initializes the next round of iterations.  The values of M1 
used to initiate the model are presented in Table 3-6. 
Table 3-6:  Values of M for Iterative Rounds 
 
Round 1 Round 2 % Difference 
M1 4859.79 4860.14 0.01% 
 
The rounds of iterations continue until the difference between Qi and si values is small 
enough to meet our stopping rule of less than 1% difference.  As mentioned previously, this 
specific example needed 2 rounds of iterations with each round requiring 11 iterations to reach 
convergence.  Upon completion of Round 2, the resulting Qi values are used once again in the 
Power Approximation formula to set to determine the corresponding si values for the sample 
items.  Table 3-7 shows the calculated values of Qi and si for the sample and supports the 
decision to stop the iterations after 2 rounds.  
Table 3-7:  Order Quantities and Reorder Points for Sample  
 
Iteration 1 Iteration 2 % Change 
 
 
Qi(1) si(1) Qi(2) si(2) Q s 
 Drug 1 122.89 59.95 122.89 59.90 0.00% 0.08% 
 Drug 2 122.62 34.23 122.62 34.21 0.00% 0.07% 
 Drug 3 120.03 26.00 120.03 25.98 0.00% 0.10% 
 Drug 4 51.11 25.99 51.11 25.97 0.00% 0.07% 
 Drug 5 71.48 17.86 71.48 17.85 0.00% 0.08% 
 Drug 6 66.34 15.82 66.34 15.81 0.00% 0.11% 
 Drug 65 24.95 2.96 24.95 2.96 0.00% 0.09% 
 Drug 66 28.75 2.19 28.75 2.18 0.00% 0.17% 
 Drug 67 35.88 6.87 35.88 6.85 0.00% 0.27% 
 Drug 68 18.92 5.40 18.92 5.40 0.00% 0.10% 
 Drug 69 18.77 4.48 18.77 4.47 0.00% 0.10% 
 Drug 70 30.68 1.72 30.68 1.72 0.00% 0.13% 
 
     





3.3.2  Demonstration of Model 3 
 In contrast to the complexity of Model 2, a significant benefit of Model 3 is that it 
provides a much simpler and less cumbersome approach to optimizing the order quantities.  A 
benefit of this approach is the need for relatively few inputs, which satisfies a major obstacle 
facing the hospital pharmacy.  At present, the hospital and GPO were unable to provide any cost 
related data.  It simply did not exist within the pharmacy database.  In addition, something as 
basic as extracting accurate usage data for transactions at the Pyxis® units is a very arduous task.  
According to the pharmacy staff, usage data can only be extracted for a period of 6 days at a 
time.  Pulling enough data for accurate analytical purposes is labor-intensive and taxes an 
already over-worked staff. 
 Once the model inputs are identified, the calculations are uncomplicated with a single, 
straightforward stopping rule.  The model inputs include the average daily demand, the standard 
deviation of daily demand, and the unit size along with the current inventory control policy used 
by the hospital (shown in Tables 3-8 and 3-9).  This information is used to initialize the iterative 
procedure. 




The hospital control settings (s, S) provide the initial values necessary to determine the 
space available for cycle stock, M0, given the reorder points.  From this, the starting values for Qi 
are established.  These order quantities are then used in the first iterative step to modify the si 
values for the sample items, which creates a new value of M, M1.  A comparison is then made 
between M0 and M1.  According to our stopping rule, the iterations continue until the change in 
M values from one step to the next is less than 1%.  The changes in M values are shown in Table 
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3-10.  Using this approach, convergence is usually reached quickly and only required 2 iterations 
in this optimization example. 
Table 3-9:  Inputs for Model 3 
Drug Average Sigma Size (vi) 
Drug 1 16.63 13.10 2 
Drug 2 10.54 8.50 1 
Drug 3 8.29 6.97 1 
Drug 4 7.60 5.54 5 
Drug 5 5.28 4.81 1.5 
Drug 6 4.76 4.30 2 
Drug 65 0.70 1.24 1 
Drug 66 0.69 1.03 1.5 
Drug 67 0.68 2.33 1 
Drug 68 0.68 1.67 2 
Drug 69 0.67 1.49 2 
Drug 70 0.66 0.85 1 
 
Table 3-10:  Percent Change in Space Available to Cycle Stock (M) 
 
Initial Iteration 1 Iteration 2 
M 5357.58 4904.59 4859.79 
% Change --- 9.24% 0.92% 
 
 Once the final values of si and Qi are found, the difference between the reorder point and 
the order up to level, Di, can be set according to the formula (47) and used to calculate the Si 
values for the items, where Si = si + Di.  The values of si and Qi from the iterations are shown in 




Table 3-11:  Optimal Values from Model 3 
 
Initial Iteration 1 Iteration 2 Optimal Values 
Drug si(0) Qi(0) si(1) Qi(1) si (2) Qi(2) Di si Si 
Drug 1 49.90 117.08 60.59 107.19 61.86 106.21 92.73 61.86 154.59 
Drug 2 31.62 131.80 33.53 120.66 34.36 119.55 110.86 34.36 145.22 
Drug 3 24.87 116.90 26.18 107.02 26.87 106.04 98.97 26.87 125.84 
Drug 4 22.81 50.06 26.09 45.83 26.58 45.41 39.59 26.58 66.17 
Drug 5 15.84 76.17 17.50 69.73 17.98 69.10 64.27 17.98 82.25 
Drug 6 14.29 62.65 16.08 57.35 16.49 56.83 52.51 16.49 69.00 
Drug 65 2.11 34.04 2.48 31.16 2.62 30.88 29.42 2.62 32.04 
Drug 66 2.08 27.63 2.23 25.29 2.32 25.06 23.96 2.32 26.28 
Drug 67 2.05 33.57 7.20 30.74 7.66 30.45 26.13 7.66 33.79 
Drug 68 2.05 23.74 4.76 21.73 5.01 21.53 19.16 5.01 24.17 
Drug 69 2.02 23.55 3.96 21.56 4.16 21.36 19.38 4.16 23.54 
Drug 70 1.99 33.04 1.66 30.24 1.73 29.97 29.09 1.73 30.83 
 
3.4  Accuracy of the Approximations 
 We examine the accuracy of our approximations for the three key performance 
indicators: 
• the expected total number of orders (daily refills), 
• the maximum space requirement for the total cycle stock, and 
• the average service level. 
 
We compare our approximations based on Model 3 with the result of using simulations of daily 
transactions.  We applied various parameter settings and in the simulation we used the real 
demand observed at a particular Pyxis MedStation® of the case hospital for a year.   
 For illustration, in Table 3-12, we summarize our results based on the same case example 
we used in the previous part of this Section for the selected 70 drugs in the particular Pyxis® 
with the highest demand rate.  We examine the performance characteristics – calculated and 
simulated – for the three inventory control policies: the supplier suggested (GPO), the one 
modified by the hospital (HM), and our approximate optimization Model 3 (OM). The maximal 
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space available (M) is set to be the same for each policy, which is equal to the volume that is 
currently used by the HM policy for the total cycle stock. 
Table 3-12:  Accuracy of the Approximations - Comparison of the Calculated and 
Simulated Key Performance Indicators 
Simulation Results 
  Inventory Policy Refills Max Space SL 
GPO 6.20 5845.75 99.95% 
HM 5.86 5898.50 99.98% 
OM 4.52 5691.50 99.98% 
    Model Predictions using our Approximation 
 Inventory Policy Refills Max Space SL 
GPO 6.03 5860.75 99.89% 
HM 5.74 5931.50 99.84% 
OM 4.47 5921.50 99.94% 
    Percent Difference 
  Inventory Policy Refills Max Space SL 
GPO -2.86% 0.26% -0.05% 
HM -2.05% 0.56% -0.14% 
OM -1.12% 3.88% -0.05% 
 
 As the above illustration in Table 3-12 shows the percent errors are below the 4% margin 
with significantly lower errors on the measure of average service level.  Overall, these results 
effectively demonstrate the accuracy of our approximations.  However, it is important to note 
that we observed that below 99% there is a tendency of underestimating the average service level 
for low demand rate. We discuss the reason for this phenomenon in the next paragraph. The daily 
usage rate is in the 16.63 to 0.66 range for the 70 items we considered.  35% of the items are 
below the 1 unit daily usage rate. As our detailed investigations revealed, these low-usage items 
are the main sources of the approximation errors. Disregarding them, the approximation error 





Figure 3-2:  Approximation of Target Service Level 
Figure 3-2 shows the average service level simulated for the 70 items for different target 
service levels.  While the accuracy of the average service level approximation we achieved using 
simulation is good for the 99% target service level and above, there is a large error at the lower 
average service levels.  To explain this phenomenon we need to examine service at the item 
level.  This observed error can be explained by the absence of shortages for many of the low 
usage rate items.  76% of the low-usage items showed no shortage during a year period.  The 
remaining 24% of these items typically had one shortage occasion and displayed high demand 
variability with all shortage items having a standard deviation of daily demand that was 2 to 3 
times the amount of average daily demand for the item (this is the so-called “lumpy” demand).  
Correcting the error at the lower average service levels would allow for an increase in stockouts 
and more accurate service level estimate.   However, this is impractical in our case given the 
expense of emergency refills and sensitivity of patient care.  On one hand we can conclude that 
low volume items and “lumpy” demand items need better service level approximation, but on the 
other hand this is not so important for our practical case because their total safety stock 
contribution is small. 
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CHAPTER 4:  ANALYSIS AND MANAGERIAL INTERPRETATION  
In this chapter the focus is on describing the decision support tool developed for this 
project and the managerial interpretation of the analysis performed.  To facilitate this research 
and to make this endeavor more applicable and beneficial for the stakeholders at the participating 
hospital, a great deal of consideration was given to their current operations and the manner in 
which inventory data is utilized.  First, the rationale for the decision support tool and software 
selection is given.  Second, comparisons are made between the efforts to achieve optimization 
using Models 2 and 3.  Third, a comparison is made to evaluate the estimated inventory costs of 
employing the current hospital policy, Model 2 results, and the Model 3 control values.  Finally, 
the operational, tactical, and strategic implications of the findings are explored and used to 
illustrate the practical value of this work.  To that end, a number of managerial tradeoffs are 
considered along with comparisons amongst allocation strategies.   
4.1  Application for Managerial Decision Support 
 For this project a modeling application and simulation were developed using MS Excel.  
There are a number of reasons this software was chosen.  First, the demand and usage data is 
available for extraction and manipulation in a file format compatible with this program.  The IT-
based solution currently employed by the hospital to monitor and control pharmaceutical 
inventory works quite well with this software.  Second, pharmacy administrators are very 
familiar with this application, as well as, with the MS Office Suite.  MS Excel is used 
extensively by the staff and is one of the most commonly used spreadsheet applications around 




Data from the identified Pyxis MedStation® is extracted at the transaction level, which is 
then manipulated into daily usage values.  Once the data is in this form, the average daily 
demand and the standard deviation of daily demand is calculated for input into the quantitative 
models.  The formulae and iterative processes (as described in Chapter 3) are incorporated into 
the application such that changes in control parameters are readily available for review 
throughout the procedure.  An added benefit of having the daily usage data for every item in a 
local depot is the ability to verify the accuracy and utility of the calculated par values.  In 
addition, now that the application has been tested and the accuracy established, the iterations of 
the models can be automated in MS Excel by setting a predetermined stopping value (i.e. 0.01) 
within the program when the difference between iterations is small.  This is ideal for managers 
that have limited amounts of time to devote to optimizing operating settings and that have little 
interest in the steps necessary to achieve the final values.  
 Ideally, this application would be incorporated into the workings of the pharmacy, which 
is a relatively easy task, due to the utility of the program and the ease of its use.  Furthermore, to 
achieve a greater potential impact on the critical performance indicators, mechanisms for 
updating inventory control parameters are easily added.  For example, forecasting techniques, 
such as exponential smoothing or moving averages, might prove useful in monitoring product 
demand and adjusting the formulary to take advantage of the tradeoffs explained here.  Also, the 
continuous review of inventory at any given Pyxis MedStation® and across all of these machines 
allows for real-time evaluation of the control values and facilitates swift changes and 
adjustments to settings as necessary. 
4.2  Levels of Decision Support 
 This section identifies the manner in which the simplified approach of Models 2 and 3 
supports decision making at multiple levels.  First, the operational decisions are discussed.  
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Second, the tactical considerations are presented along with the utility of this decision support 
tool in analyzing managerial tradeoffs.  Third, a breakdown of the strategic implications is 
provided.  
4.2.1  Operational Decision Support 
At this level of decision making, the focus is on the management of individual items.  
The high service level requirement dictates a high reorder point, si, be used to maintain 
healthcare standards and to avoid expensive emergency refills.  Additionally, the order up level, 
Si, for each item must be reduced to accommodate the other products in the Pyxis® given the 
space constraints of the storage unit.  The reduced space for cycle stock generates a need for 
additional daily refills, which results in higher refilling costs and workloads for the pharmacy.  
Any changes at the item level can impact the operations and workloads associated with the local 
depot.  Managers needed help in evaluating their current practices and in improving these 
procedures. 
The decision support tool developed for this research project serves as a model for 
managers.  It allows them to examine changes in the formulary or item usage, to evaluate options 
for modifying the control parameters, and to choose the par values that best fit hospital and 
management criteria.  In addition, it allows for quick, simple analysis of the managerial tradeoffs 
associated with the pharmacy and storage unit capacities.  Greater details on this issue are 
provided later in this chapter. 
• Cost Comparison of Allocation Strategies  
As described above, two methods for determining the optimal par levels and order 
quantities in multi-item, single-location settings under constraints have been explored.  Here 
comparisons are made between the current hospital inventory policy (HM) and the alternative 
approaches of Model 2 and Model 3.  This is followed by comparisons between the two 
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alternative approaches.  As a reminder, the hospital currently uses a modification of the fixed 
day-supply policy suggested by the GPO.  Model 2 is designed to find the optimal allocation of 
space across all items being considered by minimizing the sum of holding and ordering costs.  
While Model 2 focused on the issue of holding and refill costs, Model 3 was established to 
satisfy an exact desire of the hospital pharmacy to minimize the daily refill load without 
consideration of holding costs.  Specifically, Model 3 minimizes the total number of expected 
refills (orders) per day for a Pyxis®, subject to the service level and storage capacity constraints.   
Although accurate cost data was unavailable from the hospital, unit prices were obtained 
using a well-known, online pharmaceutical vendor.  Despite not having exact holding cost values 
for the sample drugs, surrogate values were used for comparative purposes and to better 
understand the cost implications of these policies.  Figure 4-1 illustrates the costs as calculated 
using actual product prices.  Here the cost implications of such policies are easily observed. 
 
Figure 4-1:  Cost Comparison for Allocation Methods 
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As shown in Figure 4-1, the holding cost, refill cost, and total cost of refill and holding 
are substantially different for the three policies.  Holding costs are nearly identical for HM and 
Model 2 with the Model 3 policy resulting in holding costs around 40% higher than the other 
strategies.  Refill costs are substantially higher for the HM policy than for either Model 2 or 
Model 3 with the refilling cost being 71.1% and 83.9% higher respectively.  These higher refill 
costs result in a much higher total cost for the HM policy and is evidenced by a 52.8% higher 
cost than Model 2 and 36.4% higher cost than Model 3.  These differences are summarized in 
Table 4-1. 





Holding Cost Refill Cost Total Cost 
Model 2 1.3% -71.1% -52.8% 
Model 3 41.4% -83.9% -36.4% 
 
 
In continuing with these comparisons, it is useful to examine the differences between the 
two approaches suggested as alternatives to the HM policy.  Again, the two models are evaluated 
on the basis of holding cost, refill cost, and total cost of holding and refill.  The results are 
available in Table 4-2. 




Holding Cost Refill Cost Total Cost 
Model 3 40.6% -7.5% 10.7% 
 
Model 2 provides 10.7% lower total cost of refill and holding with much of that due to 
the 40.6% lower holding cost realized by the model.  Again, this is understandable given the 
cost-focus of this approach.  The inclusion of prices allows for allocation to be based on item 
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cost and ensures that higher costing items are kept in smaller quantities, which enables the 
savings identified previously.  On the other hand, Model 3 requires a 7.5% lower refill cost, 
which supports the desires of hospital administrators.   
It is important to reiterate that neither the hospital nor the GPO could produce accurate 
cost data to support this research.  As such, the cost analyses are performed primarily to serve 
three purposes.  First, when holding and ordering costs are unknown, Model 3 provides a 
simplified technique for approximating the optimal order quantities, Q, that minimizes the 
number of refills.  It is likely that many organizations operate without accurate cost information 
similar to our case hospital, so Model 3 offers an opportunity to assess policies and possibly 
improve upon them.  Second, as with this pharmaceutical case, holding cost was not a primary 
concern for the pharmacy.  Model 3 addresses their need to reduce refill activities, thereby 
decreasing workloads, while continuing to offer high service levels for caregivers administering 
patient treatments.  This is not to say that costs are unimportant to pharmacy management, but it 
is not the main objective.  Third, this analysis clearly demonstrates the significance of having 
accurate cost data to improve the cost performance of the supply chain and decision making.  
The comparisons with Model 2 reveal the relationship of the holding costs, hi, to setting the 
optimal order quantities, Qi, for all items.  When holding costs are high, Qi values are set lower 
to avoid elevated carrying costs.  Conversely, items with lower holding costs can be held in 
higher quantities with small penalty.  In cases where good cost data is available, the expected 
refill size Qi is proportional to the rate of ordering cost, Ki, over holding cost, hi. 
• Additional Considerations for Improved Operations 
 It may be unrealistic for practitioners to re-run the approximation methods every time a 
change is proposed in the formulary.  The demand for drugs changes on a daily basis, and items 
are added and removed from the formulary frequently.  It may be too demanding to run the 
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iteration procedure each time a change occurs.  Thus, some suggestions are offered as support for 
improving the day-to-day operations of the pharmacy.  After an initial run of Model 3 to identify 
the reorder point and set the optimal order quantities, the pharmacy can employ an abbreviated 
technique since some of the variables in this equation will remain relatively constant during a 
short period of time.  The optimal si values are provided by the Power Approximation (11) and 
set to satisfy the service level requirement.  Using the final values from the initial run for the 
space available for cycle stock (see Table 3-10 for values of M), and our calculated W of 131.97 
as determined by formula (41), we can provide a quick approximation of Qi for any item 
according to formula (45).  As explained previously, the optimal space allocation for Qi to 
minimize the expected number of orders is proportional with the square root of the demand over 
volume rate.  Knowing the appropriate si and Qi values, the order up to level can be set according 
to Si = si + Qi – ui.  It is important to note that this is not the exact optimal solution; however, it 
will provide a good estimate of the solution until the next optimization run for the Pyxis® is 
made by the pharmacy.   
 Similarly, we propose a fast, simple approximation technique using the initial optimized 
values of Model 2.  Using the final value of λ (see Table 3-2) from the initial optimization run 
and the formula (23) for Qi, a good estimate of the optimal Qi value can be generated.  Since the 
reordering costs remain fairly constant over short periods of time and an appropriate holding cost 
is known, this formula can be applied by simply inputting the proper values of average daily 
demand and the unit size requirement.  Again, this does not provide the exact optimal solution, 
but the simplified nature of this approach makes it a good alternative until another optimization 
run is made for all items in the Pyxis®.  It allows pharmacy workers to make quick 
approximations of the optimal order quantity for an item any time a new drug is added to the 
formulary or when there is significant change in the average usage of an item.   
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Another important relationship to recognize is the influence that the rate of variance in 
daily demand to average daily demand (σ2/d) has on inventory policy.  The current hospital 
policy of a modified, fixed-days demand approach means that the reorder points for all items in 
the Pyxis® are set on average to be 3 days of expected demand.  Understanding the influence of 
variance in daily demand and incorporating the σ2/d ratio into the inventory policy can improve 
the operations.  When this rate is large with the variance of daily demand being 2-3 times or 
more than that of the average daily demand, the pharmacy may consider modifying the policy 
according to the Power Approximation (11) and set a higher reorder point and lower the order up 
to level (i.e. use a 4, 6 policy not 3, 10).  This higher reorder point allows the pharmacy to avoid 
stockouts and emergency refills and offers a mechanism for detecting atypical usage patterns.  In 
addition, the lower order up to level enables the pharmacy to avoid keeping unnecessarily large 
inventory of low usage items.  On the other hand, when the rate is lower with the variance of 
daily demand being equal to or much smaller than the average daily demand, then the hospital 
may consider lowering the reorder point and set the a higher order up to level (i.e. use a 2, 12 
policy not 3, 10).  Since orders are filled within 1 day by both the pharmacy and the drug 
supplier, replenishing inventory should not be a problem.  Thus, the additional space allocated to 
an increased cycle stock limits the refill occasions for these items. 
Both of the simple rules above offer improvements to current hospital pharmaceutical 
management practices.  In addition, according to pharmacy information, technicians have limited 
access to usage data and only have the ability to extract 1 week’s worth of usage data at a time.  
Since data availability and worker capacity is limited, employing this abbreviated technique and 
understanding the influence of demand variability on inventory policy can greatly enhance 
pharmacy practices at the operational level.  Models 2 and 3 demonstrates the ability to address 
both the managerial goals of the pharmacy and to offer significant quantitative support for 
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workers charged with daily tasks in the pharmacy.  The pharmacy can make optimization runs 
less frequently (i.e. every month or quarter) or only when substantial changes in the formulary or 
item demands have occurred.   
4.2.2  Tactical Decision Support 
In this section discussion shifts to “What If” analysis and the managerial implications of 
the findings demonstrated previously.  The benefits and ability of Model 3 to outperform both 
GPO and current hospital practices has already been established in the previous chapter.  Now, 
we demonstrate what happens if we make various changes to the current operating procedures 
and conditions.  
• Safety Stock and Cycle Stock Allocation Strategies 
Another important practical significance of Model 3 is to provide simple approximation 
to the optimal safety stock and cycle stock allocation strategy. There is also a relationship 
between the allocation strategy and operational control: how to select the near-optimal min and 
max par levels (s and S).  This is shown below. 
The safety stock is determined by the choice of the reorder point, s. The reorder point, s, 
is the sum of expected demand during the lead time plus the safety stock. The lead time is the 
refill time, which is one day in our case. According to the Power Approximation (11), the 
appropriate reorder point selection, providing the required α service level, depends also on the Q 
value. However, this influence is marginal compared to the effect of the α and demand 
parameters (mean and variance). Based on this observation, we can separate the allocation 
strategy for the min par levels from the allocation of the max par levels and provide a simple 
approximate strategy for the allocation of s as a function of the demand variability.  
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Considering the demand variability provides a significant improvement in the consistent 
allocation of safety stock compared to the simplistic fixed day-supply strategy suggested by the 
supplier (GPO) and also to the modified allocations based on local pharmacy experiences. We 
summarize the results of the comparisons next starting with the service level comparison. 
Table 4-3:  Policy Comparison with Constant Space Utilization (M) 
Inventory Control Policy Avg. Service Level  Service Level Range Avg. daily Refills 
GPO Suggested (GPO) 99% 7.15% 5.56 
Hospital Modified (HM) 99% 5.14% 5.74 
Our Model 3 (OM) 99% 0.44% 4.70 
 
In Table 4-3, we examine the performance of the three inventory control policies (GPO 
Suggested, Hospital Modified, and Our Model 3) when the space availability (M) is set to be 
the same for all approaches, equal to the value that is currently used by the hospital (HM) policy. 
First, we evaluate the three approaches on the issue of service level. As shown above, all three 
policies perform very well on the average service level criteria with Our Model 3 (OM) 
outperforming the others in the consistency of the service level, measured by the service level 
range (max – min service level) achieved across all items in the Pyxis® unit. With respect to the 
number of refills required per day, the OM method outperforms both of the other approaches, 
which is a primary goal of our project. 
Table 4-4:  Policy Comparison with Constant Service Level (SL) 
Inventory Control Policy Space Used Service Level Range Avg. daily Refills 
GPO Suggested (GPO) 99% 3.94% 6.03 
Hospital Modified (HM) 100% 5.14% 5.74 




Next, we compare the policies when a fixed average service level of 99% is set. Table 4-4 
above presents the findings. In this case we notice that while the GPO and HM policies require 
essentially the same amount of storage space to achieve the required 99% service level the OM 
policy needs only 82% of that space to meet the same requirement. In addition, the OM policy 
offers a much more consistent level of service across the items found in the Pyxis®. The range in 
service level is less than half of a percent (0.44%) compared to 3.94% and 5.14% for the GPO 
and HM policies respectively. Further, employing the OM suggested par values resulted in 
slightly lower numbers of refills than the GPO or HM policy, which is noteworthy given the 
substantial difference in the amount of space used for inventory in this approach, under this 
service level constraint.  The additional space available for use with the OM policy allows for 
greater flexibility in formulary changes and pharmaceutical management.  As such we can 
increase the space allocation for cycle stocks to use the full capacity of the Pyxis®.  In doing so, 
we exceed the service level requirement and can further reduce the expected number of daily 
refills in the Pyxis®.  These results are summarized in Table 4-5 below. 
Table 4-5:  Policy Comparison with Constant Service Level and Increased Space  
Inventory Control Policy Avg. Service Level Service Level Range Avg. daily Refills 
GPO Suggested (GPO) 99% 3.94% 5.56 
Hospital Modified (HM) 99% 5.14% 5.74 
Our Model 3 (OM) 99% 0.44% 4.70 
 
Finally, we examine the changes in performance indicators if we set all of the average 
number of daily refills for each competing policy, equal to the refill number achieved by the 
current HM policy. We see in Table 4-6 that the OM policy uses less space (82%) than the GPO 
(99%) or HM (100%) inventory policies. All three policies perform well on the measure of 
average service level with all methods exceeding the 92% mark; however, the HM and OM 
77 
 
policies demonstrate the ability to deliver exceptional service by surpassing the 99% level.  As 
shown previously, the OM policy continues to offer a more consistent service level at the item 
level than either of the other two management policies. 
Table 4-6:  Policy Comparison with Constant Number of Daily Refills (N) 
Inventory Control Policy Space Used Avg. Service Level  Service Level Range 
GPO Suggested (GPO) 99% 92.00% 27.60% 
Hospital Modified (HM) 100% 99.84% 5.14% 
Our Model 3 (OM) 82% 99.93% 0.44% 
 
One of the main results from the practical point of view is that the optimal allocation 
strategy of the space for the order quantities (cycle stock) of the items is proportional with the 
square root of the demand over space rate. Comparing with different allocation schemes (like 
proportionally with demand, or volume) it is interesting to verify the value of the right space 
allocation in reducing the total number of expected orders per day. We have compared five 
different allocation strategies for several examples. Table 4-7 summarizes the average percent 
increases in the total number of refills applying an allocation rule that is different from the 
optimal one. 
Table 4-7:  Comparison of the Different Space Allocation  
The expected refill size Qi is proportional to  Percent increase in total # of orders per day  
SQRT(di/vi) – the  optimal 0% 
Demand rate, di 10% 
Unit space requirement, vi 400% 






• Changes in Holding Costs 
 In this section we examine the influence the holding cost has in determining the optimal 
order quantity for Pyxis® items when Model 2 is used as the allocation method.  The allocation 
depends on the cost rate of Ki / hi where hi = r ci and ci is the unit price for an item.  Specifically, 
the inventory holding cost rate, r, used to set the holding costs for the formulary items is 
manipulated. We select different r values to observe the resulting changes in both the iterative 
procedure and the optimal order quantities generated.  In the demonstration of Model 2 provided 
in Chapter 3, a daily holding cost rate of 0.002 (r = 0.002) was used.  In this analysis we modify 
this rate to reflect increases or decreases in holding costs and discuss the outcomes. 
 In Table 4-8, a summary of the changes in the available space for cycle stock, V, is 
presented.  Here we show the starting values of V as calculated using formula (19) and the 
resulting final value of V achieved as a result of the second round of iterations.  First, one can 
see that smaller rates, which result in smaller holding cost, have a greater starting value of V.  
For example, r1 = 0.001 starts with a V’ = 25278.49 and is significantly larger than V’ of either r2 
(r2 = 0.002) or r3 (r3 = 0.003), which are 17874.59 and 14594.55 respectively.  However, the final 
values of V reached at the conclusion of the iterative procedure are nearly identical for all three 
rates.  This provides evidence of the convergence to the value of the available space for cycle 
stock and the optimal solution achieved by this allocation strategy.  Another notable observation 
is that the use of r3 yielded convergence in fewer steps (10) than either of r1 or r2, which required 
one additional iterative step to yield optimal values. 
Table 4-8:  Comparison of Space Available for Cycle Stock (V) at Varying Holding Costs 
 
V' Vfinal Iterations 
r1 = 0.001 25278.49 4817.43 11 
r2 = 0.002 17874.59 4844.36 11 




 Next, we summarize the percent change that occurs from the initial value of V’ to the 
value of V provided by the final iteration.  These are available in Table 4-8.   
Table 4-9:  Percent Change of Space Available for Cycle Stock (V) at Varying Holding 
Costs 
 
V' Vfinal % Change 
r1 = 0.001 25278.49 4817.43 80.94% 
r2 = 0.002 17874.59 4844.36 72.90% 
r3 = 0.003 14594.55 4867.37 66.65% 
 
As demonstrated by Table 4-9, the holding cost rate influences the amount of change 
needed to reach the final value of space available for cycle stock.  With an extreme value of r1, 
the difference between the initial and final values of V was nearly 81%.  As the r value is 
increased, it appears that the initial amount of space needed is a better starting value for the 
iterative procedure and requires less correction to reach the optimal value.  This is shown by the 
smaller percentages of change for r2 (72.90%) and r3 (66.65%).   
The demonstration provided in Chapter 3 used a rate of r2 = 0.002 to determine the 
holding costs of drugs.  Here we examine the impact of increasing or decreasing this rate has on 
the values of V.  In Table 4-9 the comparison is made between r2 and the 2 other holding cost 
rates of r1 = 0.001 and r3 = 0.003. 
Table 4-10:  Impact of Changing Holding Costs on Available Space (V) 
 
Percent Difference (%) 
  V' Vfinal 
r1 = 0.001 29.29% 0.56% 
r3 = 0.003 -22.47% 0.47% 
 
 As evidenced by Table 4-10, changes in the holding cost rate and holding cost will 
influence the initial estimate of space needed for cycle stock.  If the value of r is decreased from 
0.002 to 0.001, these results indicate a difference of 29.29% between the starting values of V’ 
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with the value associated with r1 being that much larger than the corresponding value of r2.  In 
addition, if the holding cost rate is increased from 0.002 to 0.003, the initial value of V’ for r3 is 
22.47% smaller than that of r2.  Again, this supports the assertion that the higher holding cost 
rates provide starting values of V’ that are closer to the actual space requirement of cycle stock.  
The above results also support the ability of this allocation technique to converge on the optimal 
solution regardless of the holding cost rate and subsequent holding costs.  The final values of V 
are almost identical for all three rates, which is evidenced by the small differences of less than 
0.56% across the three values. 
 Next, we demonstrate the changes in the optimal order quantity resulting from the 
varying inventory holding cost rates.  As explained previously, the hospital pharmacy and the 
GPO were both unable to provide unit prices or accurate holding cost data.  Unit prices were 
obtained from a well-known, online pharmaceutical vendor.  Table 4-11 presents an example of 
the prices used in this analysis.   
Table 4-11:  Optimal Order Quantities (Qi) at Differing Holding Costs 
  
Q Values with Different r 
Drug Price ci r = 0.001 r = 0.002 r = 0.003 
Drug 1  $               5.90  116.04 122.89 126.75 
Drug 2  $             17.97  123.35 122.62 119.10 
Drug 3  $               5.43  114.72 120.03 122.25 
Drug 4  $             30.38  49.00 51.11 51.89 
Drug 5  $             25.17  71.59 71.48 69.67 
Drug 6  $               3.96  62.34 66.34 68.80 
Drug 65  $             60.76  27.84 24.95 22.53 
Drug 66  $               5.90  27.28 28.75 29.49 
Drug 67  $               1.00  33.54 35.88 37.42 
Drug 68  $             86.81  20.42 18.92 17.44 
Drug 69  $             86.81  20.26 18.77 17.30 





Using the above unit prices, we were able to study the changes that occurred in Qi values 
at the three holding cost rates.  Table 4-11 shows the impact holding costs have on the allocation 
of space within the Pyxis® as items of greater costs are kept in lower quantities. These findings 
demonstrate the relationship between holding costs and the optimal Qi values.  In general, as the 
holding cost rate used to determine the holding costs increases the resulting Qi values will 
increase.  Thus, there is a reduced penalty associated with carrying greater inventory.  However, 
it is important to recognize that Qi will not always increase with increases in r values, which is 
due to the influence of demand characteristics (i.e. average daily demand and standard deviation 
of daily demand) of individual items in setting the reorder points and ultimately calculating the 
optimal order quantities.   
 Next, we summarize the observed differences in optimal order quantities across the three 
levels of holding cost rate.  Specifically, pairwise comparisons are made to show the overall 
differences (%) that result when this rate changes.  In Table 4-12, the following measures are 
provided:  average difference, absolute average difference, standard deviation of change, 
minimum difference, and maximum difference. 
Table 4-12:  Pairwise Comparisons of Percent Differences for Varying Holding Cost  
 
Qi1 and Qi2 Qi2 and Qi3 Qi1 and Qi3 
Average Percent  Difference 2.46% 3.34% 5.15% 
Absolute Avg. Difference 6.92% 5.51% 11.66% 
Standard Deviation of Change 6.61% 4.64% 10.20% 
Minimum Difference 0.03% 0.15% 0.06% 
Maximum Difference 24.86% 16.72% 37.42% 
 
 These results report the differences in optimal ordering values observed as we move from 
one level of holding cost to another.  Since some Qi values will increase and others will 
decreases as the holding cost rate is modified, it is useful to look at the overall average change 
82 
 
that occurs with shifts in rate.  One can see from Table 4-12 that there is a 2.46% average 
increase in Qi values across all items when the holding cost rate shifts from r1 (0.001) to r2 
(0.002) with a slightly greater increase of 3.34% when the value changes from r2 to r3 (0.003).  
As expected, this difference is even greater when the disparity in rates is larger, which is 
evidenced by the r1 to r3 comparison that yielded a 5.15% increase in Qi values.  With respect to 
the absolute average difference, we see that the difference in optimal order quantities is 6.92% 
and 5.51% for the first pair-wise comparisons with the change being almost 12% when the rate 
increased from r1 to r3.  The move from r2 to r3 yielded the smallest standard deviation in change, 
which was followed by the r1 to r2 and finally r1 to r3.  The minimum percent changes were nearly 
the same for each pairwise comparison with each having items that exhibited less than 0.15% 
difference in Qi values at the specified rates; however, this was not true for the maximum 
differences in Qi.  When the rate changes from r2 to r3, the largest maximum change value occur 
was 16.72%, which was the lowest observed maximum change across the comparisons.  Again, 
this was followed by the shift from r1 to r2 at 24.86% and finally r1 to r3 at 37.42%. 
4.2.3  Strategic Decision Support 
This research focused on healthcare SCM issues as they related to pharmaceutical 
inventory management within the hospital; however, there are a number of additional 
stakeholders interested in the product formulary.  As previously established in the beginning of 
this work, these stakeholders all have their own objectives, which are often at odds.  At the heart 
of this issue is tradeoff between product variety and economies of scale.  Physicians value their 
prescribing autonomy and push pharmacy directors and hospital administrators to offer a wider 
selection of drugs.  Pharmacy directors are constantly negotiating with the GPO over this same 
issue.  According to pharmacy managers at the participating hospital, efforts are made to 
accommodate doctors and to offer greater variety, but product and operational costs are also a 
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concern.  Unfortunately, the cost impacts of changes in the product formulary are not 
documented and remain essentially unknown to these parties.  We estimate the influence of these 
costs using our models to provide valuable information for the hospital when negotiating with 
doctors or the GPO on issues related to the formulary and pharmaceutical inventory 
management.  
A significant benefit of using this decision support tool is the allowance of quick 
evaluations of the managerial tradeoffs, which facilitates strategic decision making in the 
pharmacy.  When suggestions are made that impact the number of workers or work shifts 
available in the pharmacy or when changes to the formulary are discussed, the pharmacy director 
can quickly analyze the issues based on our models and computation and identify the resulting 
changes in service levels, workloads, and operating costs. 
• Analysis and Interpretation of the Tradeoffs for the Hospital Inventory Management 
Besides the simple and fast computation, the practical importance of the simplified 
approximate Model 3 is the straightforward and efficient way of showing the tradeoffs in 
pharmaceutical supply management.  It provides a simple and efficient strategic decision support 
tool to analyze the tradeoffs among the three key performance indicators: 
• the service level (emergency refill workload),  
• the available space (depending on the variety of drugs – formulary), and 
• the number of orders (refill workload) per day. 
 Next we summarize the most important aspects of the tradeoffs. 
The refill workload of a day for a Pyxis MedStation® is  
N = the expected number of total orders (refills) per day.  
The optimal N can be approximated by 
  N* = ∑ (di /Qi) = W2 / M.        (38) 
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The tradeoff between the number of orders and free storage space for a given service 
level can be expressed in the simple form 
  N M = W2.         (39) 
In this expression W = ∑√ (vi di) is fixed, it depends only on the number of drugs (formulary) 
and on the volume and demand of drugs. The parameter M = M’ - ∑[vi (si - ui)] is the remaining 
free storage space for cycle stock. Since si depends on the service level, implicitly equation (39) 
also includes the service level tradeoff. M decreases with an increased service level requirement. 
• Managerial Tradeoffs:  What-if and Sensitivity Analysis 
This section of the chapter identifies several key managerial tradeoffs and demonstrates 
the utility of this research in modeling the critical issues for management.  Specifically, we 
examine the impacts of changing formulary, available space, and worker capacity on our primary 
performance measures. For a fixed service level the tradeoff curve has a hyperbola shape that is 
shifted to the right (higher space requirement) with increasing service level requirement. This 
property allows a simple visual tradeoff analysis, and a simple example is illustrated next. 
In this research we use the example of a particular Pyxis MedStation® of the case 
hospital for illustration. All transactions (demand, refill, inventory position) and control 
parameters (si, Si) for two years are available in Excel files. The number and composition of 
drugs (formulary) is changing from time to time. We use the same example as before for 
illustration and selected 70 drugs with highest usage rate out of the 214 drugs. These items make 
up 71% of the total usage and around 70% of the total volume of the Pyxis®.  For available 
volume, M’, we took away the space used by the remaining low volume items that were 





Figure 4-2:  Performance Indicator Relationships and Tradeoffs 
Figure 4-2 illustrates the relationship between available space for cycle stock, M, and 
average daily refills, N, at a given service level. Consider what happens when the available space 
increases at the 95% service level. As space availability increases, one can read the decrease in 
the average number of daily refills from the graphs. For example, if we double the space 
allocated for items from 300 to 600, the number of orders will decrease from 9 to 5. 
Understanding this relationship between space and refills allows us to analyze what will happen 
if we change service levels. As such, if we shift from 95% to 99% service level at the same space 
utilization, the graph demonstrates the expected increase in the refill requirements. Consider 
what happens at a fixed storage capacity level of 600. As the service level increases from 95% to 
99%, the expected number of refills per day increases approximately by 25%.  
The available space is directly connected to the formulary (the number of different drugs 
provided). Even if the total demand for the drugs doesn’t increase, a bigger number of items 
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require a larger amount of safety stocks. The safety stock increase is proportional to the 
variability of demand. For lower level of demand, typically the σ/µ rate increases decreasing the 
available free space for cycle stock. For estimating a more accurate effect of increased formulary 
a more detailed comparison of the reorder points is required based on formula (32) and (33). 
• Changes to the Available Space and Product Formulary 
 As established early in this work, there are a number of important stakeholder conflicts 
present throughout this supply network.  The formulary is at the center of many of these 
disagreements and represents a substantial area of cost for the organization.  Next we investigate 
the effects of adding or removing items from a Pyxis®.  The inclusion of extra items means that 
less space is available at the item level for cycle stock in the Pyxis®.  As such, reducing the 
number of items stored in the Pyxis® will have the opposite effect as more space becomes 
available for cycle stock for individual items in the machine.   
In Table 4-13 a simple demonstration of the formulary changes and the resulting 
influence on pharmacy workload is provided.  Again, we start with the sample of 70 drugs found 
in a particular Pyxis MedStation® and modify the product mix to include or omit 20% of items 
in the local storage unit.  To establish a reasonable idea of the impact such changes to the 
formulary will have on the number of expected refills (N), we consider both high usage and low 
demanded items for the situation where items are added.  In contrast, we only consider the low 
usage items for circumstances where items are removed from the Pyxis®, which is practical 
given the small likelihood of high usage items being eliminated from the formulary.  This allows 
pharmacy directors to gain valuable insight into the cost implications resulting from introducing 





Table 4-13:  Impact of Adding or Subtracting Items to Local Formulary 
Changes in Formulary Expected Number of Daily Refills (N) 
% 
Difference 
Baseline (70 items) 3.58 --- 
20% Additional High Usage Items 5.31 48.32% 
20% Additional Low Usage Items 4.08 13.97% 
20% Fewer Items 2.70 -24.58% 
 
 As shown above in Table 4-13, increasing or decreasing the number of items in the 
Pyxis® will influence the numbers of expected daily refills needed for the machine.  It is 
important to recognize the impact these scenarios will have on the operational, tactical, and 
strategic decisions facing managers.  Another key issue is the relationship average daily demand 
and demand types have on impacting this measure.   
Regardless of the daily demand, adding items will raise the number of refills.  First, 
consider the situation where low usage or “lumpy” demand items are added to the local depot.  In 
this case one can observe approximately a 14% increase in the expected daily refills at the 
Pyxis®.  This additional workload may seem relatively small; however, this is only for one 
machine.  Considering the participating hospital has over 85 Pyxis MedStations® distributed 
around the facility in various CUs, this increased workload poses significant problems from both 
a cost and worker capacity perspective.  Second, we examine the effect of adding high usage 
items with daily demand values similar to the top 20% of items currently housed in the Pyxis® 
unit.  If such products are added to the formulary, results indicate an increase in expected daily 
refills of more than 48%.  On the other hand, we noticed almost a 25% drop in refills when the 
bottom 20% of drugs in the product formulary were removed.  This demonstrates the importance 
of both reasonably restricting the product formulary and evaluating the items in the Pyxis® on a 
frequent basis for possible reductions.  Again, these results are significant for managers 
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attempting to understand the influence of product variety on pharmaceutical inventory control 
and management.   
• Changes to Worker Capacity 
 In this context the number of refills that can be accomplished by pharmacists and 
technicians during an 8-hour shift is relatively fixed.  Pharmacists provide oversight of the 
refilling process due to the sensitive nature of controlling pharmaceuticals and the need to verify 
the prescribed medications before distributing these treatments to the patients.  Pharmacy 
technicians are responsible for preparing drug carts used in transporting items from the pharmacy 
to the Care Units (CUs) and in the actual restocking of the Pyxis®.  As a result, any increases in 
the number of refills required at the CUs can only be satisfied through incremental increases in 
the number of work shifts.  As the service level increases, one expects that smaller numbers of 
items require refills on a daily basis to prevent expensive stockout occasions.  On the other hand, 
higher service level, and the resulting higher safety stock, takes away space from cycle stock 
increasing the expected number of regular refills per day.  Table 4-14 provides a simple 
illustration of these relationships. 
Table 4-14:  Incremental Increases to Worker Capacity 
 
Refills 
Shifts 95% SL 99% SL 
1 10 15 
2 20 30 
 
Knowing this relationship and the expected number of refills required at any given 
Pyxis® allows managers to better schedule human resources and ensure that the workload does 
not exceed worker capacity.  By optimizing the allocation of space within the Pyxis® such that 
the number of expected refills is minimized, the hospital pharmacy has the ability to keep 
workloads at a controllable level and track changes over time.  Control charts are useful in 
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monitoring workloads and in determining if the workloads are exceeding preset limits, which 
indicates that conditions have changed and require attention.  If the total workload for the system 
is determined and the number of workers is known, managers can create a control chart using the 
maximum, minimum, and average workloads to determine if the system is exceeding worker 
capacity.  If so, the hospital must add workers to satisfy that excess workload.  As an example, 
demand and the composition of items in the formulary can change over time.  Trends indicating 
workloads are approaching the pharmacy capacity limits indicate a need to reevaluate 
pharmaceutical inventory control values and possibly adjust the number of technicians or work 
shifts refilling the machines. 
4.5  Summary of Findings 
 This chapter provided a description of the decision support tool, its design, and its utility.  
In addition to this, numerous illustrations were provided demonstrating the decision support 
capabilities of Model 2 and Model 3.  With the consideration of holding and refill costs, Model 2 
outperforms Model 3 in that it provides an allocation strategy which minimizes the sum of these 
two costs.  However, Model 3 is superior when holding costs are unknown or ignored, as they 
are in our practical case.  This model also excels in its simplicity and ease-of-use.  Furthermore, 
several simplified approaches to implementing these models on a daily basis were presented as 
means of improving operational decisions when products are added to the formulary or when 
demand characteristics change for an individual item.  After an initial optimization run, these 
techniques offer quick managerial decision support for estimating the close to optimal order 
quantities and the min and max par levels for daily operations.  Also, the included what-if 
analyses provide invaluable information to administrators at the tactical and strategic levels of 
decision making.   
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CHAPTER 5:  CONCLUSION 
This chapter provides closing discussions of the outcomes of this work.  First, the 
contributions of this research are identified.  Then, the limitations are recognized along with 
several possible extensions of the current project.  Finally, concluding remarks are made 
concerning the project as a whole. 
5.1  Generalizability of Findings 
This work is based on inventory control models that are commonly used in practice and 
taught in academic settings.  In addition, the case hospital, its dilemmas, and its current 
management practices are believed to be commonplace amongst other such healthcare facilities.  
The basic inventory problem considered in this research addressed the management desire to 
reduce workload (emergency and daily refilling occasions) while considering a high service level 
requirements and limited space availability, which are common inventory control constraints and 
goals of managers regardless of industry.  Models 2 and 3 are adaptable to any such 
environments.  Although the product characteristics make pharmaceuticals interesting to study, 
the methods employed in this work are easily applied to any other product where similar 
management constraints are present.  For example, consider grocery stores that have large 
numbers of items to consider with varying product characteristics, limited storage capacity for 
these items, and substantial restocking activities that require considerable efforts.  Here the 
workload requirements and costs of emergency and daily refilling may be major concerns for 
management, possibly even above inventory holding cost.   In addition, this research allows for 
an easy interpretation of the operational, tactical, and strategic tradeoffs when inventory holding 
cost is also important and an optimal balance between holding and refill costs are sought.  As 
such, the results of this research are highly generalizable, and the situations in which Models 2 
and 3 can be applied are nearly limitless. 
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5.2  Contributions 
This project resulted in a number of theoretical and practical contributions that have 
furthered the existing body of knowledge in healthcare supply chain management.  The primary 
goal of this work was to improve the current pharmacy inventory management policy and to 
offer managerial support with the developed decision support tool.  This has the potential of 
being an important step toward improving the healthcare supply chain. 
5.2.1  Contributions - Theoretical  
 This dissertation provides several key theoretical contributions.  Three quantitative 
models are presented that allow for the optimal setting of inventory control parameters (s, S) 
given a multi-item, multi-location inventory management environment under multiple constraints 
(i.e. service level, available space, and workload).  Previous research in this area handle several 
aspects of this research case; however, they fail to jointly consider the challenge of multi-item 
and joint constraint with demand uncertainty or are too complex, time and data intensive for our 
practical application.  This project addresses those shortcomings and accomplishes the following:   
1. provides an extensive review of the relevant managerial and quantitative literature as it 
currently exists,  
2. presents three quantitative models for determining the optimal min and max par values 
(reorder point and order up to level) and allocating space to multiple items under multiple 
constraints, 
3. proposes two models (Models 2 and 3) and iterative procedures that both satisfy the 
aforementioned constraints and offer simplified, practical alternatives to more 
complicated optimization approaches, 
4. applies these models and demonstrates their utility and performance using actual 
pharmaceutical usage data, and  
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5. supports the inclusion of key demand characteristics (i.e. rate of daily demand variance to 
average daily usage, holding cost rate, etc.) in the optimization process. 
The quantitative models and Excel spreadsheets prepared are providing further 
managerial support for pharmacists to analyze tradeoffs between service level and cycle stock, 
test implications on cost savings and effects of parameters, and test a variety of parameter 
settings.  Furthermore, the tools facilitate the management of worker capacity. Based on refill 
capacity requirements, pharmacy directors can manage the addition of pharmacists or overtime 
and the addition of another shift of pharmacy technicians responsible for filling the Pyxis 
MedStations® around the hospital. 
5.2.2  Contributions – Practical  
This work is of utmost practical relevance as it addresses real-world dilemmas and 
concerns of hospital administrators and pharmacy managers.  The magnitude of the healthcare 
industry, ever-increasing healthcare costs, and role of pharmaceuticals within this industry 
demonstrate the importance of continued research in this area.  In addition, the stakeholders, 
products, and policies create a unique research opportunity, and this investigation provides 
detailed study of these issues.   Specifically, this dissertation offers the following contributions: 
1. It achieves the primary objective of the project and offers improvements to the 
current inventory management practices at the local hospital;  
2. It provides a decision support tool that allows for optimization of pharmaceutical 
inventory control at the local depots and that addresses managerial concerns at the 
operational, tactical, and strategic levels of decision making; 
3. It illustrates the managerial tradeoffs associated with changes in formulary, service 
level, and space availability, as well as, offers quick, simple techniques for estimating 
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optimal min and max par levels on a daily basis when such changes occur and 
complete optimization of the system is impractical; 
4. It shows the influence of holding and refill costs on optimizing inventory control 
parameters and demonstrates the benefit of including such costs in inventory policy 
comparisons. 
Furthermore, for the operational inventory decision, the approaches offered provide the 
min and max par levels that control the automated ordering system.  These parameters are based 
on near-optimal allocation policies of cycle stock and safety stock under storage space constraint.  
As proved, the suggested selection of the control parameters si and Si 
• provide consistent service level, 
• allocate the safety stock to decrease the workload of emergency refilling, and 
• allocate the cycle stock space decreasing the workload of daily refilling. 
For the tactical and strategic decisions, the presented Models 2 and 3 can be applied as a 
simple visual decision support tool to analyze the tradeoffs among the refill workload, the 
emergency workload, and the variety of drugs offered.  This work illuminates the relationship of 
these tradeoffs to the three key performance indicators at a local care unit: the expected number 
of daily refills, the service level, and the storage space utilization. 
5.3  Limitations 
 As with any complicated area of study, one must consider the limitations of the 
investigation.  Here it was necessary to restrict the scope of the project to allow for appropriate 
comparisons.  Within pharmaceutical products one can easily observe great variety in the type, 
shape, and purpose of individual drugs.  In addition, these variations often necessitate special 
handling and storage consideration both in the central pharmacy and in the local depots.  To 
facilitate the evaluation of the research models and comparisons amongst allocation strategies, 
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this study concentrated on non-controlled substances that were readily available for examination 
and that could be stored using a consistent layout within a Pyxis® unit.  All of the items in the 
sample could be stored using a matrix layout that uses dividers to separate drugs in the machine’s 
drawers.  Since the hospital has discretion in the setup of the Pyxis®, this is not a major 
limitation of this study and is a reasonable approach to analyzing this research problem.   
 Further study is necessary to examine other drug types, specifically controlled 
substances, and the various storage restrictions and requirements of these items.  There are a 
number of drawer layouts and storage options available to the pharmacy, and the greatest 
variation in storage methods is employed with these controlled substances.  Unfortunately, this 
may prove very difficult given the legal and ethical guidelines for handling such drugs.  In 
addition, the specific issue of perishability was largely ignored for this study; however, this issue 
is somewhat covered with the impact of formulary changes on optimal space allocation within 
the Pyxis®. 
Finally, the absence of a demonstration of Model 1 with optimal solution is a limitation 
of this study.  The solution of Model 1 using approximations (4) to (7) is more straightforward, 
and it could be applied to check different practical scenarios in this research case.  However, the 
managerial problem is that the ordering and shortage cost factors are very difficult to provide.  
As stated previously, the hospital pharmacy was unable to produce any specific cost data to 
support this research activity and does not include these costs in current policies.  The technical 
problem is that the large number of items (n = 250 to 300 per local depot), the nonlinearity, and 
the stochastic demand make the solution challenging and time consuming.  Given the pharmacy 
objectives and the practical requirements, this was not a feasible solution for this case.   
However, to address this limitation, actual usage data was used to construct a simulation 
of daily transactions at the local depot for all 70 items included in the sample used for analytical 
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purposes.  Using the min and max par levels for the GPO suggested policy (GPO), the hospital 
modified (HM) inventory policy, and our Model 3 (OM) policy and the daily transaction data for 
one year, this simulation tested the accuracy of model predictions by showing the reduction of 
inventory with use, indicating the amount of shortages (stockouts) when they occurred, and the 
amount and timing of refill occasions.  In addition, the simulation calculated the average 
inventory levels for each item given the three policies.  As evidenced in Chapter 3, the 
differences between model predictions and simulation results are very low and support the 
accuracy of this approach.  
5.4  Future Research Directions 
There are plenty of extension possibilities. Some of them are technical, quantitative in 
nature, others are managerial extensions. The main technical improvements include examining 
the effect of special demand types and the consideration of multiple objectives in which Multiple 
Criteria Decision Making (MCDM) tools may be applied.  Specifically, more research is 
necessary to examine the effects of low volume demand, “lumpy” demand, and auto-correlated 
demand when subsequent days have a high demand applying a treatment followed by a longer 
period without demand. 
Some of the most important managerial extensions include examining the effect of 
demand uncertainties on workload.  Specifically, it is important to determine the uncertainty of 
the workload by analytic estimation or by simulation and to determine if there is enough worker 
capacity with certain reliability.  Then, the question becomes if capacity is not enough, how 
many workers (or additional shifts) to add to satisfy that excess workload?   
Another significant extension of this research is the opportunity to provide more specified 
quantitative support for negotiations between pharmacy administrators and medical doctors by 
analyzing the effect of extending formulary and the cost vs. product variety tradeoff.  The current 
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research effort and these recommended extensions will provide further insight into stakeholder 
preferences and acceptable tradeoffs. 
5.5  Concluding Remarks 
This dissertation was introduced with a “real world” scenario of an ER supply problem 
that with variations in details will possibly be experienced at some time by individuals who read 
this work.  A broad view of characteristics that make healthcare supply chain management a very 
intriguing area of study has been presented.  The healthcare industry operates in a unique manner 
in that it has a number of special constraints all being enforced at once.  Specifically, the focus is 
on maintaining a high level of service while restraining costs, as opposed to reducing them.  In 
traditional supply chains, these variables are manipulated to achieve the optimal economic 
operating setting.  However, in the healthcare industry, tradeoffs are not as easily achieved.  
Furthermore, medicines are special products as noted by Almarsdóttir and Traulsen (2005), 
which make pharmaceutical inventory management within the hospital a prime topic for study.  
The significance of the healthcare industry is demonstrated by the provided cost 
breakdown and by conveying the importance of affordable, quality care to the described 
stakeholders.  As such, works like the current project are valuable from both the practical and 
academic perspectives.  The case is made for additional studies in this area, and an overview of 
the current endeavor and its objectives is given.  A review of current managerial and quantitative 
modeling literature in this specific area is presented.  It is important to recognize that the need for 
continued research in this domain is warranted.  Many of the proposed inventory control models 
have yet to be tested in a healthcare setting or have not been evaluated under conditions of 
varying demand types (i.e. intermittent or auto-correlated demand).  Outsourcing and VMI in 
some form are used extensively to alleviate strains on pharmacy resources and material 
management issues; however, greater study is needed to truly understand the impact of such 
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activities throughout the supply network.  Information technology plays a significant role in 
determining the success of these solutions, and the case hospital applies advanced technology in 
controlling medication throughout the hospital. The drugs are stored in the local depots (Pyxis 
MedStations®) in 86 different areas of the hospital with each area having a different selection of 
drugs. The Pyxis MedStation® registers each transaction date and quantity of demand 
(withdrawal) and each delivery (refill) and the actual inventory level. It is connected to the 
central depot (Tallyst® system) through a computer network.  It seems clear that investments in 
these resources will continue in the future as hospitals increase their reliance on the information 
created and controlled by these machines.   
The findings presented within this dissertation have a profound reach and have the ability 
to impact anyone connected to healthcare.  These results suggest alternative methods for 
allocating space for inventory within the local depots around the hospital and provide needed 
tools for managerial decision making at all levels.  The proposed models deliver simplified, 
quick quantitative approaches that allow for setting the optimal reorder points and order up to 
levels for items in a Pyxis® unit, as well as, provide managers a mechanism for demonstrating 
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APPENDIX A:  PYXIS MEDSTATION® AND MATRIX DRAWER 
 
 
Pyxis MedStation® 3500 
6-drawer main* 







Example of a Pyxis® matrix drawer that uses plastic dividers to create a variety of storage 
configurations.  This particular matrix is setup to house 40 different products; however, the 
maximum number of separate cubicles is 48.  Dividers can be added/removed to accommodate 




APPENDIX B:  POWER APPROXIMATION 
For the Power Approximation formula (11) the rational function p(yi) is defined as 




with notation  
 w =  �ln  (25/yi2) 
and with given constants: 
a0 = -5.3925569 
a1 = 5.6211054 
a2 = -3.8836830 
a3 = 1.0897299 
b0 = 1.0000 
b1 = -0.72496485 
b2 = 0.507326622 
b3 = 0.0669136868 








hi = rci r 0.002
M1 = M' - Σ[vi(si
(1)-ui)] M1 4860.14
Step 0: Q' = √(2diK/hi)
V' = ΣviQ'i V' V0 V1 V2 V3 V4 V5 V6 V7 V8 V9 V10 V11
Step 1: Q"I = (M
1/V)*Q'i V = ΣviQi 17874.59 757.39 1063.28 1484.05 2052.61 2801.62 3753.19 4898.67 4207.27 4511.35 4692.29 4791.93 4844.36
λi = diK/vi(Q'i)
2 - hi/2vi -2260.01% 28.77% 28.35% 27.70% 26.73% 25.35% 23.38% -16.43% 6.74% 3.86% 2.08% 1.08%
λ' = min λi ; λ" = max λi
Step 2: λ = (λ' + λ")/2 Step 2 λ' λ" λi Values
Step 3: Qi(λ) = √[2diK/(hi/2 + λvi) Initial 0.005 5.980 2.993 F(Q) Initial Iteration 1 Iteration 2 Iteration 3 Iteration 4 Iteration 5 Iteration 6 Iteration 7 Iteration 8 Iteration 9 Iteration 10 Iteration 11
V' = ΣviQi(λ) Iteration 1 0.005 2.993 1.499 F(QU) 2332.92 1684.32 1236.70 932.38 729.55 597.80 597.82 558.56 537.45 526.45 520.82 517.97
If V < M, then λ"=λ and QU=Qi(λ) Iteration 2 0.005 1.499 0.752 F(QL) 775.42 775.42 775.42 775.42 775.42 775.42 515.10 515.12 515.12 515.12 515.12 515.12
If V > M, then λ'=λ and QL=Qi(λ) Iteration 3 0.005 0.752 0.379 Difference 200.86% 117.21% 59.49% 20.24% -5.92% -22.91% 16.06% 8.43% 4.34% 2.20% 1.11% 0.55%
Step 4: F(QU) = Σ[K(di/Q
U) + hi(QU/2)] Iteration 4 0.005 0.379 0.192
F(QL) = Σ[K(di/Q
L) + hi(QL/2)] Iteration 5 0.005 0.192 0.099
F(QU) - F(QL) / F(QL) ≤ E Iteration 6 0.005 0.099 0.052
Iteration 7 0.052 0.099 0.075
Iteration 8 0.052 0.075 0.064
Iteration 9 0.052 0.064 0.058
Iteration 10 0.052 0.058 0.055
Iteration 11 0.052 0.055 0.054
Drug Average Sigma Size (vi) K Price ci hi Q'I = Q
U viQ'i Q"I = Q
L diK/vi(Q'i)
2 hi/2vi λi diK hi/2 λvi Qi(λ) viQ(λ)i QU QL F(QU) F(QL)
ZOFR2 16.63 13.10 2 100 6 0.0118 530.86 1061.72 144.34 0.040 0.003 0.04 1663.49 0.01 0.11 121.30 242.61 121.30 122.89 14.43 14.26
ACET3UD 10.54 8.50 1 100 18 0.0359 242.19 242.19 65.85 0.243 0.018 0.23 1053.95 0.02 0.05 121.37 121.37 121.37 122.62 10.86 10.80
SENOKOTS 8.29 6.97 1 100 5 0.0109 390.93 390.93 106.30 0.073 0.005 0.07 829.16 0.01 0.05 118.55 118.55 118.55 120.03 7.64 7.56
H100U10ML 7.60 5.54 5 100 30 0.0608 158.18 790.92 43.01 0.082 0.006 0.08 760.22 0.03 0.27 50.49 252.43 50.49 51.11 16.59 16.43
PROM25I 5.28 4.81 1.5 100 25 0.0503 144.83 217.25 39.38 0.227 0.017 0.21 528.07 0.03 0.08 70.74 106.10 70.74 71.48 9.25 9.19
KDUR20 4.76 4.30 2 100 4 0.0079 346.63 693.26 94.25 0.027 0.002 0.02 476.29 0.00 0.11 65.47 130.94 65.47 66.34 7.53 7.44
DIPH50I 4.13 3.88 1.5 100 16 0.0328 158.57 237.86 43.12 0.148 0.011 0.14 412.53 0.02 0.08 65.29 97.94 65.29 66.04 7.39 7.33
DEX4I 3.99 3.95 1.5 100 15 0.0298 163.73 245.59 44.52 0.134 0.010 0.12 398.91 0.01 0.08 64.72 97.08 64.72 65.47 7.13 7.07
NEXI40C 3.84 5.36 2 100 8 0.0156 221.84 443.68 60.32 0.053 0.004 0.05 384.47 0.01 0.11 57.83 115.66 57.83 58.57 7.10 7.02
NEUR300 3.73 4.60 1 100 115 0.2292 57.08 57.08 15.52 1.550 0.115 1.44 373.30 0.11 0.05 47.12 47.12 47.12 47.32 13.32 13.31
NYSTSUSP5ML 3.00 4.15 2 100 115 0.2292 51.19 102.38 13.92 0.775 0.057 0.72 300.27 0.11 0.11 36.80 73.60 36.80 37.04 12.38 12.35
ZOFRT 2.97 3.14 1.5 100 20 0.0399 121.91 182.87 33.15 0.180 0.013 0.17 296.73 0.02 0.08 54.38 81.58 54.38 54.98 6.54 6.49
R10V 2.65 2.92 2 100 11 0.0227 153.06 306.12 41.62 0.077 0.006 0.07 265.40 0.01 0.11 47.33 94.66 47.33 47.92 6.14 6.08
SODB650T 0.68 1.67 2 100 87 0.1736 28.07 56.14 7.63 0.587 0.043 0.54 68.39 0.09 0.11 18.78 37.56 18.78 18.92 5.27 5.26
SUCRALUD 0.67 1.49 2 100 87 0.1736 27.84 55.69 7.57 0.587 0.043 0.54 67.30 0.09 0.11 18.63 37.26 18.63 18.77 5.23 5.22
DIG125UD 0.66 0.85 1 100 18 0.0365 60.27 60.27 16.39 0.247 0.018 0.23 66.21 0.02 0.05 30.37 30.37 30.37 30.68 2.73 2.72
Sum 17874.59 4844.36 517.97 515.12
Here we start with the inputs of average daily demand, standard deviation of daily demand (Sigma), the unit size (Vi), and the unit price (ci) for each item in the sample.  To begin, we calculate the expected order quantity (Qi) using the Economic Order Quantity (EOQ) formula (13) and 
use the notation of Qi'.  Next, we determine the corresponding reorder point value (si) using the Power Approximation (11).  If the space constraint (10) is fulfilled, we set the order up to level (Si) using (14).  If the space constraint (10) is not fulfilled, we must decrease the Qi values to 
satisfy this constraint.  To accomplish this we must find the values of Qi that fit into the available space, M, defined by (16) using the initial values of si = si
(0).  We set Qi' as the upper bounds, Q
(U), on the order quantities for the iteration and determine the overall volume needed for
these values (V') using (19).  In the first iterative step we set the lower bounds, Q(L), according to (20) and calculate values for lambda (λ) using (21).  In the second iterative step we determine the overall λ value by averaging the min and max lambda values according to (22).  
In the third step, we calculate a new Qi value, which is noted as Qi(λ) using (23) and employ our decision rules.  In the fourth step of the iterative process, calculate the functions for the upper and lower bounds according to (24) and (25) and employ the stopping rule (26).  
If the relative difference is less than or equal to the preset acceptable error, which was 0.01 in this case, stop.  Otherwise, continue the iterations beginning at step two and repeat until convergence.  Using the optimal Qi values as determined by this process to recalculate 
the reorder points (si) using (11).  With the new si = si
(2) values, recalcuate M = M2 and solve sub problem 2A (17) again.  The resulting Qi values may be different than those determined in the prior step in which case new si = si
(3) values are used for new iterations until the 
difference between si and Qi is smaller than the preset accracy limit (E = 0.01).  For futher explanation of this process, reference section 3.2.1 in the text.
Step 0 Step 1 Step 3 Step 4
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*M' = Hospital M'
Step 0:  Initial Values
M' = Tmax Σ(vidi) 5931.50
M0 = M' - Σ[vi(si-ui)] 5357.58
W = Σ√(vidi) 131.97
V0 = M0
2 / 2W2 824.10
Iterative Process Iteration 1 Iteration 2
Mk = M' - Σ[vi(si-ui)] 4904.59 4859.79 M0 M1 M2
Difference 0.009 5357.58 4904.59 4859.79
% Change --- 9.24% 0.92%
Drug Average Sigma Size (vi) ui si
(0) Qi(0) si
(1) Qi(1) si 
(2) Qi(2) Di si Si
ZOFR2 16.63 13.10 2 13.48 49.90 117.08 60.59 107.19 61.86 106.21 92.73 61.86 154.59
ACET3UD 10.54 8.50 1 8.70 31.62 131.80 33.53 120.66 34.36 119.55 110.86 34.36 145.22
SENOKOTS 8.29 6.97 1 7.07 24.87 116.90 26.18 107.02 26.87 106.04 98.97 26.87 125.84
H100U10ML 7.60 5.54 5 5.82 22.81 50.06 26.09 45.83 26.58 45.41 39.59 26.58 66.17
PROM25I 5.28 4.81 1.5 4.83 15.84 76.17 17.50 69.73 17.98 69.10 64.27 17.98 82.25
KDUR20 4.76 4.30 2 4.32 14.29 62.65 16.08 57.35 16.49 56.83 52.51 16.49 69.00
OSCALD500 0.69 1.03 1.5 1.11 2.08 27.63 2.23 25.29 2.32 25.06 23.96 2.32 26.28
LEUCO5T 0.68 2.33 1 4.33 2.05 33.57 7.20 30.74 7.66 30.45 26.13 7.66 33.79
SODB650T 0.68 1.67 2 2.37 2.05 23.74 4.76 21.73 5.01 21.53 19.16 5.01 24.17
SUCRALUD 0.67 1.49 2 1.98 2.02 23.55 3.96 21.56 4.16 21.36 19.38 4.16 23.54
DIG125UD 0.66 0.85 1 0.87 1.99 33.04 1.66 30.24 1.73 29.97 29.09 1.73 30.83
using (34) where W is set according to (35).  In the first iteration step adjust the reorder points and find the si
(1) values that provide the required service level, α, for each item 
using (11) and then find the new value of M1 using (44).  Next, we use these new values to determine the corresponding Qi
(1) values according to (45).  The iterations continue until 
convergence of M is achieved.  Once the final values of si are determined, set Si according to (46) where D is calculated by (47).  For further explanation reference section 3.2.3 of the text.
using (3).  To initialize the iteration, set the reorder point (si
(0)) using (30) and then calculate the initial value of M0 according to (31).  Next, calculate the order quantity (Qi
(0))
Here we start with the inputs of average daily demand, standard deviation of daily demand (sigma), and the unit size (vi) for each item.  We then calculate the undershoot quantity (ui)
Step 1Step 0 Step 3Step 2
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hi = rci r 0.002
M1 = M' - Σ[vi(si
(1)-ui)] α 0.99 V' V0 V1 V2 V3 V4 V5 V6
Step 0: Q' = √(2diK/hi) M' 4200.00 V = ΣviQi 27587.67 2315.08 2890.78 3405.89 3116.85 2997.44 3055.39 3085.66
V' = ΣviQ'i M1 3080.84
Step 1: Q"I = (M
1/V)*Q'i V' 27587.67
λi = diK/vi(Q'i)
2 - hi/2vi Step 2 λ' λ" λi Values
λ' = min λi ; λ" = max λi Initial 0.032 0.198 0.115 F(Q) Initial Iteration 1 Iteration 2 Iteration 3 Iteration 4 Iteration 5 Iteration 6
Step 2: λ = (λ' + λ")/2 Iteration 1 0.032 0.115 0.073 F(QU) 270.93 218.12 218.12 218.12 210.59 206.72 206.72
Step 3: Qi(λ) = √[2diK/(hi/2 + λvi) Iteration 2 0.032 0.073 0.052 F(QL) 225.98 225.98 186.18 202.78 202.78 202.78 204.76
V' = ΣviQi(λ) Iteration 3 0.052 0.073 0.063 Difference 19.89% -3.48% 17.15% 7.56% 3.85% 1.94% 0.96%
If V < M, then λ"=λ and QU=Qi(λ) Iteration 4 0.063 0.073 0.068
If V > M, then λ'=λ and QL=Qi(λ) Iteration 5 0.063 0.068 0.065
Step 4: F(Q
U) = Σ[K(di/Q
U) + hi(QU/2)] Iteration 6 0.063 0.065 0.064
F(QL) = Σ[K(di/Q
L) + hi(QL/2)]
F(QU) - F(QL) / F(QL) ≤ E
Drug Average Sigma Size (vi) ui K Price ci hi EOQ si
(1) vi(si-ui) Q'I = Q
U viQ'i Q"I = Q
L diK/vi(Q'i)
2 hi/2vi λi diK hi/2 λvi Qi(λ) viQ(λ)i QU = Qi(λ") Q
L F(QU) F(QL)
DRUG 1 10.00 10.00 5 10 100 5 0.0100 447.21 47.47 187.34 447.21 2236.07 68.08 0.043 0.001 0.04 1000.00 0.01 0.32 55.41 277.03 54.86 55.41 18.50 18.33
DRUG 2 10.00 10.00 5 10 100 2 0.0040 707.11 47.41 187.06 707.11 3535.53 107.65 0.017 0.000 0.02 1000.00 0.00 0.32 55.66 278.31 55.11 55.66 18.26 18.08
DRUG 3 10.00 10.00 2 10 100 5 0.0100 447.21 42.20 64.39 447.21 894.43 68.08 0.108 0.003 0.11 1000.00 0.01 0.13 86.61 173.22 85.78 86.61 12.09 11.98
DRUG 4 10.00 10.00 2 10 100 2 0.0040 707.11 42.05 64.11 707.11 1414.21 107.65 0.043 0.001 0.04 1000.00 0.00 0.13 87.60 175.21 86.74 87.60 11.70 11.59
DRUG 5 10.00 4.00 5 5.8 100 5 0.0100 447.21 25.35 97.73 447.21 2236.07 68.08 0.043 0.001 0.04 1000.00 0.01 0.32 55.41 277.03 54.86 55.41 18.50 18.33
DRUG 6 10.00 4.00 5 5.8 100 2 0.0040 707.11 25.33 97.65 707.11 3535.53 107.65 0.017 0.000 0.02 1000.00 0.00 0.32 55.66 278.31 55.11 55.66 18.26 18.08
DRUG 7 10.00 4.00 2 5.8 100 5 0.0100 447.21 23.78 35.96 447.21 894.43 68.08 0.108 0.003 0.11 1000.00 0.01 0.13 86.61 173.22 85.78 86.61 12.09 11.98
DRUG 8 10.00 4.00 2 5.8 100 2 0.0040 707.11 23.74 35.87 707.11 1414.21 107.65 0.043 0.001 0.04 1000.00 0.00 0.13 87.60 175.21 86.74 87.60 11.70 11.59
DRUG 9 5.00 5.00 5 5 100 5 0.0100 316.23 21.33 81.67 316.23 1581.14 48.14 0.043 0.001 0.04 500.00 0.01 0.32 39.18 195.89 38.79 39.18 13.08 12.96
DRUG 10 5.00 5.00 5 5 100 2 0.0040 500.00 21.31 81.53 500.00 2500.00 76.12 0.017 0.000 0.02 500.00 0.00 0.32 39.36 196.80 38.97 39.36 12.91 12.78
DRUG 11 5.00 5.00 2 5 100 5 0.0100 316.23 18.76 27.53 316.23 632.46 48.14 0.108 0.003 0.11 500.00 0.01 0.13 61.24 122.49 60.66 61.24 8.55 8.47
DRUG 12 5.00 5.00 2 5 100 2 0.0040 500.00 18.70 27.39 500.00 1000.00 76.12 0.043 0.001 0.04 500.00 0.00 0.13 61.95 123.89 61.34 61.95 8.27 8.20
DRUG 13 5.00 2.00 5 2.9 100 5 0.0100 316.23 11.99 45.46 316.23 1581.14 48.14 0.043 0.001 0.04 500.00 0.01 0.32 39.18 195.89 38.79 39.18 13.08 12.96
DRUG 14 5.00 2.00 5 2.9 100 2 0.0040 500.00 11.98 45.42 500.00 2500.00 76.12 0.017 0.000 0.02 500.00 0.00 0.32 39.36 196.80 38.97 39.36 12.91 12.78
DRUG 15 5.00 2.00 2 2.9 100 5 0.0100 316.23 11.20 16.61 316.23 632.46 48.14 0.108 0.003 0.11 500.00 0.01 0.13 61.24 122.49 60.66 61.24 8.55 8.47
DRUG 16 5.00 2.00 2 2.9 100 2 0.0040 500.00 11.18 16.56 500.00 1000.00 76.12 0.043 0.001 0.04 500.00 0.00 0.13 61.95 123.89 61.34 61.95 8.27 8.20
Sum 1112.27 27587.67 3085.66 206.72 204.76
Here dummy values are used in sensitivity analysis.  The calculations are identical to those used with the actual pharmacy data, which are described in Appendix C.  
This analysis was done to demonstrate the influence of the various product characteristics on the determination of the optimal control parameters and order quantities.
Step 0 Step 1 Step 3 Step 4
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*M' = Hospital M'
Step 0:  Initial Values
M' = Tmax Σ(vidi) 4200.00
M0 = M' - Σ[vi(si-ui)] 3271.80
W = Σ√(vidi) 78.82
V0 = M0
2 / 2W2 861.49
Iterative Process Iteration 1 Iteration 2
Σ[vi(si-ui) 1101.51 1118.74
Mk = M' - Σ[vi(si-ui)] 3098.49 3081.26 M0 M1 M2
Difference -0.006 3271.80 3098.49 3081.26
% Change --- -5.59% 0.56%
Drug Average Sigma Size (vi) ui si
(0) Qi(0) si
(1) Qi(1) si 
(2) Qi(2) Di si Si
DRUG 1 10.00 10.00 5 10.00 30.00 58.70 47.08 55.59 47.70 55.28 45.28 47.70 92.99
DRUG 2 10.00 10.00 5 10.00 30.00 58.70 47.08 55.59 47.70 55.28 45.28 47.70 92.99
DRUG 3 10.00 10.00 2 10.00 30.00 92.82 41.65 87.90 42.30 87.41 77.41 42.30 119.71
DRUG 4 10.00 10.00 2 10.00 30.00 92.82 41.65 87.90 42.30 87.41 77.41 42.30 119.71
DRUG 5 10.00 4.00 5 5.80 30.00 58.70 25.23 55.59 25.42 55.28 49.48 25.42 74.90
DRUG 6 10.00 4.00 5 5.80 30.00 58.70 25.23 55.59 25.42 55.28 49.48 25.42 74.90
DRUG 7 10.00 4.00 2 5.80 30.00 92.82 23.61 87.90 23.81 87.41 81.61 23.81 105.42
DRUG 8 10.00 4.00 2 5.80 30.00 92.82 23.61 87.90 23.81 87.41 81.61 23.81 105.42
DRUG 9 5.00 5.00 5 5.00 15.00 41.51 21.14 39.31 21.45 39.09 34.09 21.45 55.54
DRUG 10 5.00 5.00 5 5.00 15.00 41.51 21.14 39.31 21.45 39.09 34.09 21.45 55.54
DRUG 11 5.00 5.00 2 5.00 15.00 65.63 18.50 62.15 18.81 61.81 56.81 18.81 75.62
DRUG 12 5.00 5.00 2 5.00 15.00 65.63 18.50 62.15 18.81 61.81 56.81 18.81 75.62
DRUG 13 5.00 2.00 5 2.90 15.00 41.51 11.93 39.31 12.03 39.09 36.19 12.03 48.22
DRUG 14 5.00 2.00 5 2.90 15.00 41.51 11.93 39.31 12.03 39.09 36.19 12.03 48.22
DRUG 15 5.00 2.00 2 2.90 15.00 65.63 11.12 62.15 11.22 61.81 58.91 11.22 70.13
DRUG 16 5.00 2.00 2 2.90 15.00 65.63 11.12 62.15 11.22 61.81 58.91 11.22 70.13
Here dummy values are used in sensitivity analysis.  The calculations are identical to those used with the actual pharmacy data, which are described in Appendix D.  
This analysis was done to demonstrate the influence of the various product characteristics on the determination of the optimal control parameters and order quantities.
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